syndrome	score	normalized_score
DRAVET SYNDROME	2.8321856999999993	100.0
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.0206696799999997	71.3466521633804
BIRDSHOT CHORIORETINOPATHY	2.00826446	70.90864345512374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	70.61683843682992
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	53.69495545436871
PITUITARY APOPLEXY	1.3804945100000001	48.743078887800344
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.320621654	46.62906298834855
PERIPHERAL CONE DYSTROPHY	1.25	44.135524023018704
DIGEORGE SYNDROME; DGS	1.2266153729999998	43.309849809636425
MYOCLONIC-ASTASTIC EPILEPSY	1.2192351540000002	43.04926594326073
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	42.14744817050662
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15814036	40.89210534464602
TURCOT SYNDROME WITH POLYPOSIS	1.111111	39.23157298619226
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.0781868099999998	38.06907188324551
RETINITIS PIGMENTOSA 75; RP75	1.0666667	37.66231500992327
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	1.066017619	37.63939698586856
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.02930401	36.34309748827558
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.0291128189999998	36.33634683629679
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0149112699999998	35.83491259065393
MOWAT-WILSON SYNDROME; MOWS	1.0102613289999998	35.67073052448503
IDIOPATHIC INTRACRANIAL HYPERTENSION	1.00826446	35.600224236708776
EHLERS-DANLOS SYNDROME, TYPE I	1.0	35.30841921841496
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	35.30841921841496
BROWN SYNDROME	1.0	35.30841921841496
STRABISMUS, SUSCEPTIBILITY TO	1.0	35.30841921841496
LEBER CONGENITAL AMAUROSIS 17	1.0	35.30841921841496
MYOCLONIC EPILEPSY OF LAFORA	0.94270522	33.285431107148106
CRANIOPHARYNGIOMA	0.7988433730000001	28.205896703736634
LAFORA DISEASE	0.7819456599999999	27.60926516930017
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.77869296	27.494417474108428
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	27.209271623679204
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	26.431139878998756
MENINGIOMA	0.735725	25.977286729468346
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.721475014	25.474142249923805
EARLY MYOCLONIC ENCEPHALOPATHY	0.720372604	25.435217895493228
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.69182474	24.427237945590935
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.6877593499999999	24.283695451184574
ROLANDIC EPILEPSY	0.6114546	21.58949534982823
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.61096717	21.5722849670486
COG4-CDG	0.596351694	21.056235613363917
TSH-SECRETING PITUITARY ADENOMA	0.595264119	21.017835059332448
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684	20.97208526969118
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.5893574	20.809278148675073
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5885869730000001	20.78207558918189
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.58524564	20.664098402869563
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.57970205	20.46836300317455
SPINOCEREBELLAR ATAXIA TYPE 10	0.5755583	20.322053741038243
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.5683460090000001	20.067399146885045
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5588439999999999	19.731898229695886
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	19.615790023938057
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.550180064	19.425988345326374
PLACENTAL INSUFFICIENCY	0.53522694	18.898017174509434
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.831145147014908
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	18.608490255423582
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	18.414045519684677
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.519276729	18.33484043789926
INHALATIONAL ANTHRAX	0.5172414	18.262976188319858
PERSISTENT PLACOID MACULOPATHY	0.5133333	18.124987355172372
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.512980369	18.112525919469196
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	18.084799312417974
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.507604834	17.922724276165937
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.902860324448362
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.5027009	17.749574118674495
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.5023323030000001	17.736559541275852
RESTRICTIVE DERMOPATHY	0.50189394	17.721081636702003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501086973	17.69258890757058
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	17.65420960920748
PAROXYSMAL HEMICRANIA	0.5	17.65420960920748
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	17.65420960920748
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	17.65420960920748
CREST SYNDROME	0.5	17.65420960920748
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	17.65420960920748
PINEOCYTOMA	0.5	17.65420960920748
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5	17.65420960920748
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.47239697999999997	16.679590607353187
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.468482674	16.54138265015603
PINEOBLASTOMA	0.464368929	16.39613281713837
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	15.956690269285668
NELSON SYNDROME	0.4519231	15.956690269285668
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.442944399	15.639666530340865
CONGENITAL MYASTHENIC SYNDROME	0.442944399	15.639666530340865
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43686985000000006	15.425183807686063
JUVENILE GLAUCOMA	0.43124969999999996	15.226745195415683
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42581059400000004	15.034698960594293
DUANE RETRACTION SYNDROME 1	0.42514088	15.01105241792585
ACUTE BILIRUBIN ENCEPHALOPATHY	0.42276401900000005	14.92712921331395
DUANE-RADIAL RAY SYNDROME; DRRS	0.41791163	14.755799028291122
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.4095316	14.459913415988229
NON-DISTAL MONOSOMY 20Q	0.401688479	14.182985211739474
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.37351412999999994	13.188193486041541
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.368045154	12.995092588738094
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	12.872034132507629
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.364298264	12.862795825852807
LEBER HEREDITARY OPTIC NEUROPATHY	0.3581731	12.646525967559263
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.357688054	12.629399760051047
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.623383417266746
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	12.623383417266746
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.355925534	12.567167965010206
CENTRALOPATHIC EPILEPSY	0.35470090000000004	12.523928074349083
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34778266	12.279655956175477
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.347573019	12.272253863862108
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.347573019	12.272253863862108
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34726515999999996	12.261383849229944
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34605429	12.218629943650944
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.200051006542406
PROLACTINOMA	0.34526411900000004	12.190730254728711
NON-FUNCTIONING PITUITARY ADENOMA	0.34526411900000004	12.190730254728711
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.34410232999999996	12.149709321673365
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.34180758	12.06868532667191
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34173636	12.066170661055175
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34037525	12.018112018572797
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.018112018572797
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	11.813431937037182
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	11.788723952670196
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	11.769461303331912
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	11.769461303331912
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.769461303331912
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	11.769461303331912
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.33194444	11.72043344474199
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32399068999999997	11.439599105383524
XQ21 MICRODELETION SYNDROME	0.31899900299999995	11.26335052818041
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.637770468228833
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.2991457	10.562361782986196
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29177275	10.302034573509784
OPTIC ATROPHY 1; OPA1	0.28798984	10.168466001364248
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28798984	10.168466001364248
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.2849752	10.062023828451647
RETINAL CAPILLARY MALFORMATION	0.283056	9.994259910287665
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.282337273	9.96888279606807
NARP SYNDROME	0.278387673	9.82942866352302
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27616419000000003	9.750920993634002
MARFAN SYNDROME; MFS	0.27066968	9.556918531154228
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.26912256	9.502292169613034
WILLIAMS-BEUREN SYNDROME; WBS	0.26769956	9.452048289065228
RETINOSCHISIS OF FOVEA	0.26520889999999997	9.36410702165469
SLC35A2-CDG	0.264633454	9.343788933049131
ALLAN-HERNDON-DUDLEY SYNDROME	0.26322136	9.293930126121323
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.26013600000000003	9.184990941801594
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.2599044	9.17681351191061
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.154034638336041
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	9.126328827943736
CATARACT 7; CTRCT7	0.25826446	9.118909822897562
UVEAL MELANOMA	0.25826446	9.118909822897562
NEOVASCULAR GLAUCOMA	0.25826446	9.118909822897562
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.25768663899999994	9.098507876796356
TRICHOTHIODYSTROPHY	0.25696008400000003	9.072854368271123
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.25609701900000004	9.042380907438382
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.256035929	9.040223916108328
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.025889580616132
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	9.021107267083513
OPTIC ATROPHY 9; OPA9	0.25549451	9.021107267083513
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.255418049	9.018407550041653
PALLISTER-HALL SYNDROME	0.252439494	8.913239481436548
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	8.846367453942024
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.250541419	8.846221453628553
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.250541419	8.846221453628553
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.25	8.82710480460374
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	8.82710480460374
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	8.82710480460374
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	8.82710480460374
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24444441	8.630945703878105
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244048764	8.616976069048016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.581540186436223
RETINITIS PUNCTATA ALBESCENS	0.2366153	8.354512205891021
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.211725311655943
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.230957884	8.154757790070052
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	7.977201141860157
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.22359056300000002	7.894629331685421
POLYARTERITIS NODOSA	0.2208333	7.797274733785997
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.21720738000000003	7.669249230373562
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.215610734	7.612874184062155
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.213878854	7.551724238986168
PITUITARY CARCINOMA	0.21382781	7.549921956035583
USHER SYNDROME TYPE 3	0.21096707	7.448913748840695
CRI-DU-CHAT SYNDROME	0.21070892000000002	7.4397988804194615
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20986120000000003	7.409867227279626
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20900901000000002	7.379777745505886
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.20847458000000002	7.360907867022988
RETINITIS PIGMENTOSA 18	0.2083333	7.35591949355581
SLC39A8-CDG	0.20672819899999997	7.299245914559911
JUVENILE MYOCLONIC EPILEPSY	0.2042519	7.21181171135777
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.20416972000000003	7.2089100654664025
USHER SYNDROME TYPE 1	0.20250361400000003	7.150082496356086
PREECLAMPSIA/ECLAMPSIA 1	0.202435359	7.147672520202332
LINEAR VERRUCOUS NEVUS SYNDROME	0.201786749	7.124771126413075
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.201086973	7.10006314204609
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.080946493021275
ROMANO-WARD SYNDROME	0.200541419	7.080800492707808
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.200541419	7.080800492707808
EPISODIC ATAXIA, TYPE 4	0.2	7.061683843682992
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.061683843682992
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.061683843682992
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.061683843682992
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.061683843682992
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.2	7.061683843682992
HELLP SYNDROME	0.2	7.061683843682992
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.061683843682992
MALARIA	0.2	7.061683843682992
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.061683843682992
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.061683843682992
CARPENTER SYNDROME	0.2	7.061683843682992
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.2	7.061683843682992
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.061683843682992
BENIGN SCHWANNOMA	0.2	7.061683843682992
UNILATERAL POLYMICROGYRIA	0.19630751	6.931307858803186
ADNP SYNDROME	0.19161293899999998	6.765549977884573
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.431003235416381
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.400915519063599
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.400915519063599
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.17785471399999997	6.279768801883296
RIFT VALLEY FEVER	0.17547247900000001	6.195655849826516
USHER SYNDROME TYPE 2	0.17493106000000003	6.1765392008017015
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.174899193	6.175414027406467
MUCOLIPIDOSIS TYPE II	0.17407441	6.146292243478245
MACULAR CORNEAL DYSTROPHY	0.173611	6.129929968928239
CEREBROOCULONASAL SYNDROME	0.17269110000000001	6.0974497540892205
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.17266914999999997	6.096674734287374
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.01759813983949
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.16971255	5.99228186202621
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496	5.958823957059032
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496	5.958823957059032
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.168435409	5.947188032197184
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.167753973	5.9231276042386645
SPINOCEREBELLAR ATAXIA TYPE 13	0.167753973	5.9231276042386645
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.167208419	5.903864954900381
POSTENCEPHALITIC PARKINSONISM	0.167208419	5.903864954900381
DERMATOLEUKODYSTROPHY	0.166667	5.884748305875567
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	5.884748305875567
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	5.884748305875567
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.166667	5.884748305875567
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	5.884748305875567
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.16192107399999997	5.71717716108799
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.15811721899999998	5.582869054101926
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.156639614	5.5306971573227015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.469163056645615
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15390714399999997	5.434217961060957
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.150545654	5.315529062942449
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.241651350757122
JOUBERT SYNDROME 5	0.14769169000000001	5.214760105596185
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.14518930299999996	5.126404776353471
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.14498452299999998	5.119174318265925
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14464788399999998	5.107288127328657
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14394397299999998	5.082434142648204
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.14353632	5.068040559628559
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.044054844285106
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.044054844285106
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.139244154	4.916490963145533
XP21 MICRODELETION SYNDROME	0.13708058299999998	4.840098691268727
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.13248749999999998	4.677924191199751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.637143461320351
CONE-ROD DYSTROPHY 2	0.13071191	4.615230915119726
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13015825	4.595682055735259
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.12972122399999997	4.580251358517911
RETINITIS PIGMENTOSA 58	0.1291667	4.560671992659239
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.12824465	4.5281158647189
LISSENCEPHALY, X-LINKED, 2	0.12822341900000003	4.5273662316704755
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.12702093299999997	4.4849083518781985
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.12677254400000001	4.476138128936957
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.126768409	4.475992128623488
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.12671831300000003	4.474223318054324
GLYCOGEN STORAGE DISEASE II	0.12622699	4.456875479598674
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.125620063	4.435445846647698
HURLER SYNDROME	0.125545554	4.432815051640153
PHENYLKETONURIA	0.125541419	4.432669051326685
THORACOLARYNGOPELVIC DYSPLASIA	0.125	4.41355240230187
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.125	4.41355240230187
ADENOHYPOPHYSITIS	0.125	4.41355240230187
PANHYPOPHYSITIS	0.125	4.41355240230187
SHEEHAN SYNDROME	0.125	4.41355240230187
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	4.41355240230187
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.125	4.41355240230187
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	4.41355240230187
CENTRAL PRECOCIOUS PUBERTY	0.125	4.41355240230187
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.12480951000000003	4.4068265015249555
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.12437784399999999	4.391585057434617
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.122614673	4.329330276612866
SCHINZEL-GIEDION SYNDROME	0.12072416000000001	4.262579251071004
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.11953011000000001	4.220419233103255
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.11934559	4.213904123589073
COG8-CDG	0.11905982899999999	4.203814354404798
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.19106713235647
W SYNDROME	0.11869880399999999	4.19106713235647
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.171804483018187
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.117676519	4.154971865015773
FOVEAL HYPOPLASIA 2; FVH2	0.11660550999999998	4.117156230257077
DDOST-CDG	0.11371689900000001	4.015163942110153
BILATERAL POLYMICROGYRIA	0.11313534400000001	3.9946301543715883
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.11290198400000001	3.9863905816627785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.11287940899999999	3.985593494098922
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11235632999999999	3.967124401482573
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11235632999999999	3.967124401482573
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.11219797299999999	3.9615330661404027
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.112057244	3.9565641476122146
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	3.942416417115587
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11165241899999999	3.942270416802119
GANGLIOCYTOMA	0.11111110000000002	3.9231572986192274
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	3.923153767777304
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	3.923153767777304
MUCOLIPIDOSIS III ALPHA/BETA	0.11111099999999999	3.923153767777304
MYOTONIA, POTASSIUM-AGGRAVATED	0.11111099999999999	3.923153767777304
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.11111099999999999	3.923153767777304
SUDDEN INFANT DEATH SYNDROME	0.11111099999999999	3.923153767777304
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10903684000000001	3.8499184569712375
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.10887481899999998	3.8441977515810493
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.108691154	3.8377128307653
TRICHOHEPATOENTERIC SYNDROME 1	0.10822884	3.8213892542427583
OPTIC ATROPHY 5; OPA5	0.10817310000000001	3.8194211629555235
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10768421900000001	3.802159547659606
RING CHROMOSOME 7 SYNDROME	0.10679109	3.7706245745114817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.7694867253937496
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.10644866000000001	3.7585339125185206
BECKWITH-WIEDEMANN SYNDROME	0.10615976	3.74833331020632
MELAS	0.10553470000000001	3.726263429689657
SALT-AND-PEPPER SYNDROME	0.10543916400000002	3.7228902045512076
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.105252254	3.716290707915093
AICARDI SYNDROME; AIC	0.10491369	3.7043365482708297
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.103270484	3.646317541960614
CONGENITAL ENTEROVIRUS INFECTION	0.10256786000000001	3.6215089992156955
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.10140257400000002	3.580364592618346
NOCARDIOSIS	0.10111611900000002	3.570250319391135
SANJAD-SAKATI SYNDROME	0.100459529	3.5470671644165153
ROBERTS SYNDROME	0.09985801400000001	3.5258286206303504
SARCOSINEMIA	0.09974223400000001	3.5217406118532426
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.09921533	3.5031364645333825
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	3.5016616318626292
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.493877678995415
BOWEN-CONRADI SYNDROME	0.09885792900000001	3.490517200196302
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.09868667000000002	3.484470315629376
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09839385400000002	3.474131445547516
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.09816821	3.4661643126013963
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.46452741428643
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.46452741428643
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.46452741428643
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.46452741428643
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.46452741428643
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.097738334	3.4509860705814606
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	3.446873557761415
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.09639853999999999	3.403680062363143
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.095610474	3.3758546976633634
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.09481738	3.3478518022317543
TRISOMY 8P	0.094663299	3.342411445690162
RETINAL CONE DYSTROPHY 3B	0.09358764000000001	3.3044316267821014
PRADER-WILLI SYNDROME	0.092858149	3.2786744527380396
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.092677509	3.272296339890426
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.2576218430874797
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.09199607300000001	3.2482359119319058
20Q11.2 MICRODUPLICATION SYNDROME	0.09199607300000001	3.2482359119319058
AICA-RIBOSIDURIA	0.09145051900000001	3.2289732625936227
STURGE-WEBER SYNDROME	0.09114414900000002	3.218155822197678
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	3.2098566135688076
ROBERTS SYNDROME; RBS	0.0909091	3.2098566135688076
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	3.2098566135688076
ULBRIGHT-HODES SYNDROME	0.0909091	3.2098566135688076
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.0909091	3.2098566135688076
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	3.2098566135688076
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0909091	3.2098566135688076
RHEUMATOID ARTHRITIS	0.0901315	3.182400786784568
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.089670973	3.166140306407169
OROFACIODIGITAL SYNDROME TYPE 14	0.089272544	3.1520724082463953
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.08882781000000001	3.136369553733713
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08825100000000001	3.116003304444339
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08772485000000001	3.09742577967257
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08767721	3.0957436865810046
AICARDI SYNDROME	0.08723209999999998	3.080027556102695
ADENYLOSUCCINASE DEFICIENCY	0.086621653	3.058473637516072
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.0429628961123574
NEUROTROPHIC KERATOPATHY	0.08593211	3.0341269642029487
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08522724000000001	3.0092391187484644
8Q12 MICRODUPLICATION SYNDROME	0.08510584400000001	3.004952817889026
CITRULLINEMIA TYPE I	0.08510170900000001	3.004806817575558
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.08456049399999999	2.9856973714682624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.084429733	2.9810804072628443
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	2.961629740592223
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.082959029	2.9291521738846438
WHITE-SUTTON SYNDROME; WHSUS	0.08273389400000002	2.9212030129239066
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	2.910035524859829
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	2.9090908127952217
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.9002884238840703
GAUCHER DISEASE TYPE 2	0.08193319	2.892931420422044
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08187854400000001	2.891001956545435
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.08063971	2.847260686331409
CONE-ROD DYSTROPHY 10	0.0803653	2.8375717030136838
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.080122614	2.829002843987243
USHER SYNDROME	0.07956821	2.8094277151388773
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.07883488300000001	2.783535097998695
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.77912034511014
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.078432963	2.7693439381464295
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07829106	2.7643335675340786
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.077508983	2.7367196649569983
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.735149711404871
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	2.716033062380056
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.716033062380056
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.716033062380056
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.716033062380056
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.076504843	2.7012650688830195
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.694353692979949
HYDROXYKYNURENINURIA	0.076281954	2.693395210631846
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	2.677553947115827
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07550507999999999	2.6659650177599588
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.07524900300000001	2.656923343691765
LEIGH SYNDROME; LS	0.07498789300000001	2.647703962349645
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0749364	2.645885825918831
MONOSOMY 18Q	0.074812953	2.641527107491575
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.073777854	2.604979398067013
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.073513684	2.5956519729620844
2Q24 MICRODELETION SYNDROME	0.07296801900000001	2.5763854043892684
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07279345000000001	2.5702216489547287
PEHO SYNDROME	0.072761414	2.569090508436647
CONE-ROD DYSTROPHY 8; CORD8	0.0726908	2.566597239721958
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	2.5478982539880772
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.072110964	2.5461241471560294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.5412936023227584
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.07197001900000001	2.54114760200929
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.54114760200929
TAKAYASU ARTERITIS	0.07197001900000001	2.54114760200929
SPONTANEOUS PERIODIC HYPOTHERMIA	0.07197001900000001	2.54114760200929
SCLERODERMA	0.07197001900000001	2.54114760200929
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07154332999999999	2.526081887921403
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07154332999999999	2.526081887921403
ALAND ISLAND EYE DISEASE	0.07150901	2.5248701029738276
CLEFT LIP AND ALVEOLUS	0.07142860000000001	2.5220309529844753
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.5220309529844753
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.5220309529844753
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.5220309529844753
PYCNODYSOSTOSIS	0.07142860000000001	2.5220309529844753
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.5220309529844753
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.070574673	2.491880140486552
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.07044325399999998	2.4872399433412857
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.070351524	2.4840011020463812
FG SYNDROME TYPE 1	0.06955916300000001	2.456024087686059
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.453500842123453
DISTAL MONOSOMY 12Q	0.069239254	2.4447286066023146
SILVER-RUSSELL SYNDROME	0.0691208	2.440546183112217
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.069065519	2.4385942983894036
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.068980663	2.4355981671682057
NIEMANN-PICK DISEASE, TYPE C2	0.068980663	2.4355981671682057
JOUBERT SYNDROME 2	0.06896728399999999	2.4351257758274825
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.4254659572640316
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06856063999999999	2.4207678190028292
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	2.4194776493645884
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.068111574	2.404912008418093
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.06810997	2.4048553737136666
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.3978664252135733
LISSENCEPHALY 8; LIS8	0.067753673	2.3922750898714025
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.067753673	2.3922750898714025
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.067212254	2.373158440846588
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.067212254	2.373158440846588
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.067212254	2.373158440846588
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.067212254	2.373158440846588
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.067212254	2.373158440846588
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.067212254	2.373158440846588
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.066772329	2.357625384521927
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.066772329	2.357625384521927
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.066772329	2.357625384521927
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.066772329	2.357625384521927
RETINITIS PIGMENTOSA 41	0.0666667	2.3538957915083043
PROGRESSIVE SUPRANUCLEAR PALSY	0.0666667	2.3538957915083043
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.3538957915083043
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.3538957915083043
SPINOCEREBELLAR ATAXIA TYPE 40	0.0666667	2.3538957915083043
PERRY SYNDROME	0.0666667	2.3538957915083043
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.3538957915083043
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0666667	2.3538957915083043
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0666667	2.3538957915083043
KUFOR-RAKEB SYNDROME	0.0666667	2.3538957915083043
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0666667	2.3538957915083043
CARIBBEAN PARKINSONISM	0.0666667	2.3538957915083043
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.3538957915083043
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0666667	2.3538957915083043
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.0666667	2.3538957915083043
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0666667	2.3538957915083043
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.3538957915083043
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.3538957915083043
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.3538957915083043
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.0666667	2.3538957915083043
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.3538957915083043
CHROMOSOME 16P13.2 DELETION SYNDROME	0.066059293	2.332449210516105
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.065913673	2.3273075985095195
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.065832769	2.324451006161073
RETINITIS PIGMENTOSA 20	0.06566456	2.318511812272762
HADDAD SYNDROME	0.065513739	2.3131865611778215
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06522628	2.3030368382977153
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.06483230300000001	2.2891261332193023
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.288508129957722
LEBER CONGENITAL AMAUROSIS	0.064813963	2.2884785768108364
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.2707409334070157
OCULODENTODIGITAL DYSPLASIA	0.064236409	2.2680860580575635
DIETHYLSTILBESTROL SYNDROME	0.06395896000000001	2.258289772453834
BRONCHOPULMONARY DYSPLASIA	0.06395896000000001	2.258289772453834
AMISH INFANTILE EPILEPSY SYNDROME	0.06368481000000001	2.2486099693251056
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06326349	2.233733826140003
XQ12-Q13.3 DUPLICATION SYNDROME	0.06256965	2.2092354325494976
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	2.206776201150935
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0625	2.206776201150935
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0625	2.206776201150935
ARNOLD-CHIARI MALFORMATION TYPE I	0.0625	2.206776201150935
MULTIPLE SYSTEM ATROPHY	0.0625	2.206776201150935
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	2.206776201150935
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	2.206776201150935
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.0625	2.206776201150935
HEREDITARY METHEMOGLOBINEMIA	0.06187790900000001	2.184811151330932
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.061804412999999996	2.182216123752055
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.060068830000000004	2.120935431599701
CHROMOSOME 1P36 DELETION SYNDROME	0.059992733	2.1182485668224373
JOUBERT SYNDROME 3; JBTS3	0.05994715	2.116639103149204
HYPOPLASMINOGENEMIA	0.0596073	2.104639536877826
PGM3-CDG	0.05944951899999999	2.099068539185125
YUNIS-VARON SYNDROME	0.059369054	2.0962274472327156
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.059364919	2.0960814469192472
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.059364919	2.0960814469192472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.059364919	2.0960814469192472
17Q24.2 MICRODELETION SYNDROME	0.059364919	2.0960814469192472
MENTAL RETARDATION, X-LINKED 98; MRX98	0.059306853	2.0940312282489106
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.05926644	2.092604309103037
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.059205240000000006	2.0904434338468705
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0588235	2.0769647978944326
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.058167563	2.053804699317563
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.0486336753977685
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.04004666784385
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.05761994399999999	2.0344691380935935
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.057594530000000005	2.0335718099275772
JOUBERT SYNDROME 1	0.057328144	2.02416614136566
JUVENILE ABSENCE EPILEPSY	0.056942849999999996	2.01056201929132
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.056642573	1.9999597130936724
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.056642573	1.9999597130936724
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.056572029	1.9974689159683283
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.056106379000000005	1.9810275505592736
JOUBERT SYNDROME 7	0.056101154	1.9808430640688575
WOLFRAM SYNDROME	0.056097019000000005	1.9806970637553891
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.056097019000000005	1.9806970637553891
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05590010399999999	1.9737443063849947
CREUTZFELDT-JAKOB DISEASE; CJD	0.05579616	1.9700742080577558
APNEA, OBSTRUCTIVE SLEEP	0.0555984	1.9630916150731224
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.9615804147305742
GITELMAN SYNDROME	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.9615804147305742
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.9615804147305742
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.9615804147305742
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.9615804147305742
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.9615804147305742
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	1.9615804147305742
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.9615804147305742
17P11.2 MICRODUPLICATION SYNDROME	0.054305743999999996	1.917449975119923
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05403164900000001	1.9077721139542518
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.05387693	1.9023092306411977
ADULT-ONSET DYSTONIA-PARKINSONISM	0.053718573	1.8967178952990267
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05348399999999999	1.8884354934777052
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.053466803	1.8878282945924068
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.053247009	1.880067715898714
KUFOR-RAKEB SYNDROME	0.053173019	1.8774552459607439
INHERITED CREUTZFELDT-JAKOB DISEASE	0.053173019	1.8774552459607439
INFANTILE MYOFIBROMATOSIS	0.0530914	1.8745734080925558
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0530914	1.8745734080925558
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0526316	1.8583385969359287
SPASTIC PARAPLEGIA TYPE 7	0.0526316	1.8583385969359287
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0526316	1.8583385969359287
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0526316	1.8583385969359287
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0526316	1.8583385969359287
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0526316	1.8583385969359287
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0526316	1.8583385969359287
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0526316	1.8583385969359287
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0526316	1.8583385969359287
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0526316	1.8583385969359287
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0526316	1.8583385969359287
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.052624818999999996	1.8580991705452088
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.05252171	1.854458554748017
ZELLWEGER SYNDROME	0.052496539	1.8535698065278705
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.052440749999999994	1.851599985128094
JUVENILE XANTHOGRANULOMA	0.051742760000000006	1.826955061597833
XP22.13P22.2 DUPLICATION SYNDROME	0.05162487899999999	1.8227928698319467
PRADER-WILLI-LIKE SYNDROME	0.051568462999999995	1.8208009100533207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214000000006	1.8106586019412503
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8071244057195832
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.050781449	1.7930126898105592
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.050513743	1.783560414135274
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.05044311	1.78106647456062
ACHROMATOPSIA	0.05038954	1.7791750025430892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.049793033	1.7581132833203703
CHARGE SYNDROME	0.049612214	1.7517288502657158
ERYTHERMALGIA, PRIMARY	0.0494995	1.7477490971019316
DESMOID TUMOR	0.0494995	1.7477490971019316
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.7328261349529452
MOHR-TRANEBJAERG SYNDROME	0.04894842	1.728291333439047
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.04859377	1.7157692025632363
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04851715	1.7130638714827215
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.048288373	1.7049861172591902
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.047921654	1.6920378490718324
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.047786803	1.6872764734318098
BIOTINIDASE DEFICIENCY	0.047750204	1.6859842205968347
9P13 MICRODELETION SYNDROME	0.047677119999999996	1.6834037400866764
NEUROFIBROMATOSIS TYPE 1	0.047184279	1.6660023034506537
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.047042868999999994	1.6610093398889771
CONGENITAL DISORDER OF GLYCOSYLATION	0.047032703	1.660650394499203
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046841813999999996	1.653910405663019
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.046617570000000004	1.645992704503805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.046541473	1.6433058397265408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.046235233	1.6324929894250935
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.04622591300000001	1.632163914957978
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.046000054	1.6241891907017258
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.046000054	1.6241891907017258
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.6226584294949307
GALLOWAY-MOWAT SYNDROME	0.045855563	1.619087441900438
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.617577547969401
CONE-ROD DYSTROPHY, X-LINKED, 3	0.04575352	1.6154844648781332
YOU-HOOVER-FONG SYNDROME; YHFS	0.045693814000000006	1.6133763404002788
CHRISTIANSON SYNDROME	0.04568974	1.6132324939003826
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.045689679000000004	1.6132303400868107
AMYLOIDOSIS	0.04554079999999999	1.6079736579419919
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04551705	1.6071350829855546
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0454545	1.6049265413634428
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.04540046	1.6030184743888793
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.04537224	1.602022070798536
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.045329048999999996	1.600497064864073
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.0452822	1.59884290073211
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04514712	1.5940734394640863
GLUTAMINE DEFICIENCY, CONGENITAL	0.044985889	1.5883806277250823
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.5879453102245384
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.04497356	1.5879453102245384
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5862487406810934
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.044787629999999995	1.5813804158392581
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	1.57912067700928
PSEUDOTRISOMY 13 SYNDROME	0.04470529	1.578473120600814
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.044567273	1.573599958505546
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.569261860195114
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.5640907303500615
CANAVAN DISEASE	0.04428809	1.5637424481028914
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.044216963000000005	1.5612310661691433
OPTIC PATHWAY GLIOMA	0.044080003000000006	1.5563952250729893
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.5542666923288264
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04350680900000001	1.536156651027509
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.5351500433040113
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.5351500433040113
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.5351500433040113
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.5351500433040113
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.5351500433040113
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.5351500433040113
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.5351500433040113
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.5351500433040113
LICHTENSTEIN SYNDROME	0.043478300000000004	1.5351500433040113
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.5351500433040113
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.043320553	1.5295802460975638
DEND SYNDROME	0.043216219	1.5258963774868297
PRADER-WILLI SYNDROME; PWS	0.043153243	1.523672794478131
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.5145083883447332
49,XYYYY SYNDROME	0.04289368999999999	1.5145083883447332
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.042822559	1.5119968651773086
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.042809413	1.511532700698263
COFS SYNDROME	0.04280571899999999	1.5114022713976702
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5096661917331202
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5096661917331202
WEST SYNDROME	0.0426748	1.5067797284620148
ALG13-CDG	0.0426748	1.5067797284620148
ALPERS-HUTTENLOCHER SYNDROME	0.042616694000000004	1.5047280974549095
CHERUBISM	0.04227	1.4924868803624005
16P13.11 MICRODELETION SYNDROME	0.042255454	1.4919732840964492
SCHWARTZ-JAMPEL SYNDROME	0.042240549999999995	1.4914470474164179
COG2-CDG	0.04221225399999999	1.4904479603862133
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.4837287682089493
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.041812664	1.4763390691507272
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.041719814	1.4730606824262975
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.4711853110479303
49,XXXYY SYNDROME	0.041666699999999994	1.4711853110479303
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.4711853110479303
HISTIDINEMIA	0.041666699999999994	1.4711853110479303
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.4711853110479303
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.4711853110479303
GYRATE ATROPHY OF CHOROID AND RETINA	0.041540719000000004	1.4667371210863756
NORRIE DISEASE	0.041036808999999994	1.4489448555580238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.040928619000000006	1.4451248376827839
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.4451248376827839
MENTAL RETARDATION, X-LINKED 106; MRX106	0.040905854	1.4443210415192764
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.040888704	1.4437155021296806
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.435691875712811
OSTEOPETROSIS AND RELATED DISORDERS	0.04061194	1.4339434027931153
DOORS SYNDROME	0.040533033999999996	1.431157356666267
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.040528854	1.4310097674739342
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.04044757400000001	1.4281398991598615
OCULOCUTANEOUS ALBINISM	0.04044589999999999	1.4280807928660895
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04020156	1.419453533714262
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.040015769	1.4128935471992536
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.039858799	1.407351184634539
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.039817654	1.4058984197257973
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.039661714	1.4003924248328776
OPTIC ATROPHY 8	0.03951446	1.3951931188692892
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.3866357703875143
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039092333	1.3802884817898773
MARSHALL-SMITH SYNDROME; MRSHSS	0.03905765	1.379063879886125
LISSENCEPHALY 2; LIS2	0.038809544	1.3703036492275211
COSTELLO SYNDROME; CSTLO	0.038765644	1.3687536096238326
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.038742149999999996	1.367924073622715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.03873591900000001	1.3677040668625655
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.038535394	1.3606238460987927
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.360126209238328
CEDNIK SYNDROME	0.038492573	1.3591119042794408
1P36 DELETION SYNDROME	0.038423753	1.3566819788688294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.038421223000000004	1.356592648568207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.038298733	1.3522677202981432
MYHRE SYNDROME	0.038197682999999996	1.3486998045361223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038149659	1.3470041530115773
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.038124033	1.3460993394606862
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.3443574692153841
SCLEROSTEOSIS 1; SOST1	0.03801564	1.3422721539763447
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.038007514	1.3419852377617756
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.3375980254402107
XIA-GIBBS SYNDROME	0.037591534	1.3272976415352995
13Q12.3 MICRODELETION SYNDROME	0.037409780000000004	1.3208801951086757
X-LINKED RETINOSCHISIS	0.0374056	1.3207326059163427
CARTILAGE-HAIR HYPOPLASIA	0.03733677999999999	1.3183026805057312
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.037274100000000004	1.3160895487891213
JOUBERT SYNDROME 30; JBTS30	0.037117343	1.3105547069177
MYOCLONUS AND ATAXIA	0.037037	1.307717922592435
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.307717922592435
MCLEOD SYNDROME; MCLDS	0.037037	1.307717922592435
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.307717922592435
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.307717922592435
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.307717922592435
HALLERMANN-STREIFF SYNDROME; HSS	0.03685898	1.3014323178031726
SOTOS SYNDROME	0.036803593	1.2994766903879225
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2993947748553356
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.2973905630552407
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.2973905630552407
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.2973905630552407
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.2973905630552407
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.2973905630552407
ACHROMATOPSIA 7; ACHM7	0.03674451	1.2973905630552407
STARGARDT DISEASE	0.03674451	1.2973905630552407
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.036676943000000004	1.2950048790939102
19P13.3 MICRODUPLICATION SYNDROME	0.036415833999999994	1.2857855330602086
BAKER-GORDON SYNDROME; BAGOS	0.036275593999999994	1.2808338803490182
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.2802781258305207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.2801321255170526
SCHAAF-YANG SYNDROME; SHFYNG	0.036208803	1.278475595721001
16P13.2 MICRODELETION SYNDROME	0.036208803	1.278475595721001
ALSTROM SYNDROME; ALMS	0.036110714	1.275012228188286
SAETHRE-CHOTZEN SYNDROME	0.035953349	1.2694559187979804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03592458399999999	1.268440272119162
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.035924053000000004	1.2684215233485576
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.03590774	1.2678455371058475
SECKEL SYNDROME 2; SCKL2	0.03590774	1.2678455371058475
ROWLEY-ROSENBERG SYNDROME	0.03590774	1.2678455371058475
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.03568606999999999	1.2600187198177013
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.2593189069487924
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.2593189069487924
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035624383	1.2578406493613752
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.035520754	1.2541816731861901
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.035422659999999995	1.2507181291113787
SMITH-MAGENIS SYNDROME; SMS	0.035171673	1.2418561748970067
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.035146914	1.240981973745578
DYSOSTEOSCLEROSIS	0.035136919	1.24062906609549
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.035063313	1.238030154590499
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.034979514	1.2350713443684154
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.034948963	1.2339926368528733
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.034833984	1.229932910119559
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.22944092260617
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.03478300300000001	1.2281328515993855
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03473042	1.2262762289916231
22Q11.2 MICRODUPLICATION SYNDROME	0.034535003	1.2193763636332182
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.2151237116972946
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.034407544	1.2148759878280582
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034152039999999995	1.2058545454840763
MEIER-GORLIN SYNDROME 5; MGORS5	0.034152039999999995	1.2058545454840763
SECKEL SYNDROME	0.034152039999999995	1.2058545454840763
ISOTRETINOIN-LIKE SYNDROME	0.034152039999999995	1.2058545454840763
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03403064399999999	1.2015682446246374
CHROMOSOME 17Q12 DELETION SYNDROME	0.03397144	1.1994778449732306
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0337422	1.1913837429516012
POTOCKI-LUPSKI SYNDROME	0.033537613	1.1841600993889634
SPINOCEREBELLAR ATAXIA TYPE 34	0.03350343	1.1829531516948204
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.1829531516948204
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.1823055952863544
DENT DISEASE	0.033485089999999995	1.1823055952863544
PITT-HOPKINS SYNDROME	0.033401602999999995	1.1793578012910666
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.033377719	1.178514495006454
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032803653999999995	1.1582451673278344
NETHERTON SYNDROME; NETH	0.032803653999999995	1.1582451673278344
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.1582451673278344
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.1580991670143668
TUBEROUS SCLEROSIS-1	0.032799519	1.1580991670143668
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.1580991670143668
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1580991670143668
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1580991670143668
RETINITIS PIGMENTOSA 11	0.032795210000000005	1.1579470230359548
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.032712354	1.1550215086531934
WILLIAMS SYNDROME	0.03266388	1.1533099683399999
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.03252151	1.148283108695874
1Q21.1 MICRODELETION SYNDROME	0.032480233	1.1468256830757957
3P25.3 MICRODELETION SYNDROME	0.0324539	1.1458959064725172
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.0324507	1.1457829195310183
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1389825179895516
MILD CANAVAN DISEASE	0.0322581	1.1389825179895516
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1389825179895516
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.1389825179895516
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1389825179895516
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.1389825179895516
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1389825179895516
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1389825179895516
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.1389825179895516
THROMBOCYTOPENIA 1	0.0322581	1.1389825179895516
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.1389825179895516
COG1-CDG	0.0322581	1.1389825179895516
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1389825179895516
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1389825179895516
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1389825179895516
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1389825179895516
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.1389825179895516
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	1.1389825179895516
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1389825179895516
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	1.1389825179895516
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.1389825179895516
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1389825179895516
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1389825179895516
FETAL ALCOHOL SYNDROME	0.032256224	1.138916279395098
CARDIOFACIOCUTANEOUS SYNDROME	0.032223133999999994	1.1377479238031603
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.032136003999999996	1.13467150123666
GIANT CELL ARTERITIS	0.03207396	1.1324808256746728
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.1324808256746728
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.032062943999999996	1.1320918681285623
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.031944440000000004	1.1279076792175038
ACHONDROPLASIA	0.03169233	1.119006073648349
TYSHCHENKO SYNDROME	0.031676154	1.118434924659072
TETRASOMY X	0.031589274	1.115367329197376
PENTASOMY X	0.031589274	1.115367329197376
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.031589274	1.115367329197376
DISTAL MONOSOMY 7Q36	0.031585139	1.115221328883908
C SYNDROME	0.031585139	1.115221328883908
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.03152996	1.113273045619855
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.031483779	1.1116424675119296
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03134496	1.106740988064448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03134496	1.106740988064448
SHORT SYNDROME	0.03130574	1.1053561918627017
CRANIOSYNOSTOSIS 2	0.031295359	1.1049896551627958
COFFIN-LOWRY SYNDROME	0.031254449	1.1035451877325702
CONE-ROD DYSTROPHY 18	0.03125	1.1033881005754675
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.1033881005754675
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.1033881005754675
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1025728291757142
JOUBERT SYNDROME 23; JBTS23	0.031081414	1.0974355954131119
DOWN SYNDROME	0.03104372	1.0961046798590928
TURNPENNY-FRY SYNDROME; TPFS	0.031010894	1.0949456456898292
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.030987783999999997	1.0941296681216917
DYSTONIA 28, CHILDHOOD-ONSET	0.030831164	1.0885996635037036
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.03082266	1.0882994007066702
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.030758713000000003	1.08604153322291
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	1.0824547980734458
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03063879	1.0818072416649802
WYBURN-MASON SYNDROME	0.030628033	1.0814274289994474
KOOLEN-DE VRIES SYNDROME	0.030586293	1.079953655581271
RAVINE SYNDROME	0.030535859999999998	1.0781729460748286
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.030468094	1.0757802357380737
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03046534	1.0756829963515462
BARATELA-SCOTT SYNDROME	0.030387864	1.0729474412641802
LOWRY-MACLEAN SYNDROME	0.030302329000000003	1.069927335626333
7Q11.23 MICRODUPLICATION SYNDROME	0.030220109000000002	1.067024277398195
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.03019156	1.0660162573379284
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030110103000000003	1.063140139433654
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.030044874	1.060837006556456
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02997931	1.0585220453588198
NAVAJO NEUROHEPATOPATHY	0.029957354	1.0577468137064603
RAHMAN SYNDROME	0.029947144	1.0573863147462403
RETINAL CONE DYSTROPHY 4	0.029935669999999998	1.056981185944128
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.0533772555945045
ALG12-CDG	0.02979839	1.0521340461538242
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.02979839	1.0521340461538242
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.02979839	1.0521340461538242
COG7-CDG	0.02979839	1.0521340461538242
VASCULAR EHLERS-DANLOS SYNDROME	0.029782214	1.0515628971645472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.029756709000000003	1.0506623559323813
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0490474900710078
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.029658373000000002	1.0471902672201194
ALG1-CDG	0.029658373000000002	1.0471902672201194
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029658373000000002	1.0471902672201194
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029568353999999998	1.0440118386304966
EPILEPSY, PYRIDOXINE-DEPENDENT	0.029568353999999998	1.0440118386304966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.029564549000000002	1.043877490095371
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02954584	1.0432169048802133
SUSAC SYNDROME	0.02954106	1.0430481306363495
LEBER OPTIC ATROPHY AND DYSTONIA	0.02954106	1.0430481306363495
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.038484164368177
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.038484164368177
IMMUNE SUPPRESSION	0.0294118	1.038484164368177
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.038484164368177
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.038484164368177
MYELOPEROXIDASE DEFICIENCY	0.0294118	1.038484164368177
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.038484164368177
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.038484164368177
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.038484164368177
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.038484164368177
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.038484164368177
MONOMELIC AMYOTROPHY	0.0294118	1.038484164368177
MYASTHENIA GRAVIS; MG	0.0294118	1.038484164368177
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.038484164368177
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.038484164368177
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.038484164368177
RAGWEED SENSITIVITY	0.0294118	1.038484164368177
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.038484164368177
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.0346782698606243
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.0346782698606243
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.0346782698606243
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.0346782698606243
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.029297873999999998	1.0344616174002998
KEPPEN-LUBINSKY SYNDROME	0.029225429	1.0319036989700219
AURICULOCONDYLAR SYNDROME	0.029116954	1.0280736181953043
PROPIONIC ACIDEMIA	0.029116954	1.0280736181953043
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	1.0279276178818364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.0241132846620902
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.028864773000000003	1.0191695057283854
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.028864773000000003	1.0191695057283854
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.028864773000000003	1.0191695057283854
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.028864773000000003	1.0191695057283854
DISTAL MONOSOMY 6P	0.028817884	1.017513929259653
RENPENNING SYNDROME	0.028813749	1.0173679289461848
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.028762459	1.0155569601244725
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.028752319999999998	1.0151989680620168
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0106681917079097
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0106681917079097
EMANUEL SYNDROME	0.028583052999999997	1.0092224178661733
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.0088109688570213
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0088109688570213
HURLER-SCHEIE SYNDROME	0.0285714	1.0088109688570213
SCHEIE SYNDROME	0.0285714	1.0088109688570213
ACRODYSOSTOSIS	0.0285714	1.0088109688570213
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0088109688570213
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.0088109688570213
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0088109688570213
CHEILITIS GLANDULARIS	0.0285714	1.0088109688570213
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0088109688570213
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0088109688570213
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0285714	1.0088109688570213
ALPHA-THALASSEMIA	0.0285714	1.0088109688570213
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.0088109688570213
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0088109688570213
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0088109688570213
TETRASOMY 9P	0.028509313	1.0066187750330076
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.028509313	1.0066187750330076
STVE-WIEDEMANN SYNDROME	0.028509189999999997	1.0066144320974435
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.02827233	0.9982512799213697
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.02827233	0.9982512799213697
NANOPHTHALMOS	0.02827233	0.9982512799213697
PEHO-LIKE SYNDROME; PEHOL	0.028270504000000002	0.9981868067478771
BETA-UREIDOPROPIONASE DEFICIENCY	0.028270504000000002	0.9981868067478771
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.02822104	0.9964403110996574
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.02822104	0.9964403110996574
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.028177523000000003	0.9949037946205297
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.02794395	0.9866567012184267
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.027807463999999997	0.981837596312982
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.027799489	0.9815560116697153
GIANT AXONAL NEUROPATHY	0.027777800000000002	0.9807902073652871
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9807902073652871
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.027777800000000002	0.9807902073652871
OROFACIODIGITAL SYNDROME XVII	0.027777800000000002	0.9807902073652871
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9807902073652871
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9807902073652871
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.027777800000000002	0.9807902073652871
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.027621859999999998	0.9752842124723673
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9735432955543842
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9733972952409161
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.027327753999999996	0.9648997945297161
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	0.9639445605561813
ALEXANDER DISEASE	0.027274609000000002	0.9630233285903537
TRISOMY 13	0.027198759	0.9603451849926368
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.027178294	0.959622598193332
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.954280646216101
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.027027	0.954280646216101
HYPEROPIA, HIGH	0.027027	0.954280646216101
ACRAL PEELING SKIN SYNDROME	0.027027	0.954280646216101
BENIGN OCCIPITAL EPILEPSY	0.027027	0.954280646216101
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.027027	0.954280646216101
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.027027	0.954280646216101
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.027027	0.954280646216101
MICROPHTHALMIA, ISOLATED 1	0.027027	0.954280646216101
CRANIOECTODERMAL DYSPLASIA	0.027027	0.954280646216101
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.027027	0.954280646216101
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.954280646216101
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.026832889000000002	0.9474268936531955
RETINITIS PIGMENTOSA 19	0.02677111	0.945245574822301
RETINITIS PIGMENTOSA 10; RP10	0.02677111	0.945245574822301
RETINITIS PIGMENTOSA 83; RP83	0.02677111	0.945245574822301
CHERUBISM	0.02677111	0.945245574822301
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	0.945245574822301
RETINITIS PIGMENTOSA 79	0.02677111	0.945245574822301
RETINITIS PIGMENTOSA 72; RP72	0.02677111	0.945245574822301
RETINITIS PIGMENTOSA 14	0.02677111	0.945245574822301
ZUNICH NEUROECTODERMAL SYNDROME	0.026768409000000003	0.945150206781992
MAPLE SYRUP URINE DISEASE; MSUD	0.026768409000000003	0.945150206781992
ZIMMERMANN-LABAND SYNDROME 1	0.026768409000000003	0.945150206781992
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.026709563000000002	0.9430724475446652
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02665816	0.9412574888715809
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9356964128446807
GABRIELE-DE VRIES SYNDROME	0.026500129999999997	0.9356776993824947
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.026439254	0.9335282640541546
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02637401	0.9312246015506684
GALACTOSEMIA	0.026369563000000002	0.9310675850104042
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.026286533	0.928135926962699
LINEAR NEVUS SEBACEUS SYNDROME	0.026219949	0.9257849511774601
MICROSPORIDIOSIS	0.026047279	0.9196882464310163
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.026040463	0.9194475842456238
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.026035464	0.9192710774579508
CROUZON SYNDROME	0.025784609	0.9104137839549155
16P11.2P12.2 MICRODELETION SYNDROME	0.025745114	0.909019277937884
1P21.3 MICRODELETION SYNDROME	0.025683564	0.9068460447349905
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.025644760000000003	0.9054759368356393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025621114	0.9046410339548006
OCULOCEREBRORENAL SYNDROME OF LOWE	0.025606899	0.9041391247756109
ISOLATED PLAGIOCEPHALY	0.025600384	0.9039090904244028
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.025588783000000004	0.9034994774530501
LYNCH SYNDROME	0.025577909000000003	0.903115533702469
FAMILIAL COLORECTAL CANCER TYPE X	0.025577909000000003	0.903115533702469
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025541419000000003	0.9018271294851891
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025541419000000003	0.9018271294851891
KEUTEL SYNDROME; KTLS	0.025541419000000003	0.9018271294851891
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.025541419000000003	0.9018271294851891
TOXIC EPIDERMAL NECROLYSIS	0.025505859999999998	0.9005715974062013
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.025502843	0.9004650719054195
PYRUVATE DEHYDROGENASE DEFICIENCY	0.025484503000000002	0.8998175154969538
DPM1-CDG	0.025304819	0.893473157498112
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025147103999999997	0.8879044901610795
GORLIN-CHAUDHRY-MOSS SYNDROME	0.025138009999999995	0.8875833953967074
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.025115699	0.8867956292555255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02507556	0.8853783846165175
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.882710480460374
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.882710480460374
HOOFT DISEASE	0.025	0.882710480460374
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.882710480460374
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.882710480460374
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.882710480460374
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.882710480460374
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.882710480460374
MARFANOID HYPERMOBILITY SYNDROME	0.025	0.882710480460374
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.882710480460374
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.882710480460374
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.882710480460374
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.882710480460374
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.882710480460374
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.882710480460374
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.882710480460374
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.882710480460374
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.882710480460374
ALKAPTONURIA	0.025	0.882710480460374
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.882710480460374
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.882710480460374
3MC SYNDROME 1	0.02492624	0.8801061314588237
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.024735203	0.8733609169765955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.024587273	0.8681377425216152
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.024528009	0.866045224365055
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02451503	0.8655869563920193
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	0.8644539092193003
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	0.8644539092193003
SNEDDON SYNDROME	0.024350919000000002	0.859792456405666
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.024350919000000002	0.859792456405666
FAMILIAL THROMBOCYTOSIS	0.024350919000000002	0.859792456405666
AICARDI-GOUTIERES SYNDROME 7	0.024257513	0.8564944382001508
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.024077828999999995	0.8501500802013088
AGEL AMYLOIDOSIS	0.02399786	0.8473265012248316
HAREL-YOON SYNDROME; HAYOS	0.023945533999999997	0.8454789528808089
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.840675807380851
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0238095	0.840675807380851
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.840675807380851
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	0.840675807380851
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.840675807380851
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.840675807380851
PITUICYTOMA	0.0238095	0.840675807380851
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.0238095	0.840675807380851
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.0238095	0.840675807380851
CRYPTOCOCCOSIS	0.023806919000000003	0.8405846763508483
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.023768323	0.8392219126026943
OROFACIODIGITAL SYNDROME TYPE 4	0.023716094	0.8373777891753358
INFANTILE REFSUM DISEASE	0.023590563000000002	0.832945488002429
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023590563	0.8329454880024287
HERMANSKY-PUDLAK SYNDROME	0.02358764	0.8328422814930535
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.02358764	0.8328422814930535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023541369	0.8312085256273981
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.023518073000000004	0.8303859806932861
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.023295614	0.8225313050623765
CINCA SYNDROME	0.023295554	0.8225291865572235
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.023165603	0.8179408221713712
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.02313799	0.8169658507914932
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.023045009	0.8136828386641457
ISOLATED CEREBELLAR AGENESIS	0.023045008999999998	0.8136828386641457
6Q25 MICRODELETION SYNDROME	0.023029923	0.8131501758518168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.022952293999999998	0.8104092185763103
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.02276314	0.8037304898474703
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02272724	0.8024629175975292
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.022663584	0.8002153248637619
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.022620049	0.7986781728330881
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.022605844	0.7981766167380906
WIEACKER-WOLFF SYNDROME	0.022541333	0.7958988353058913
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.7949056447816966
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7949056447816966
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.7949056447816966
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7929054228329733
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.789622410705626
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.789622410705626
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.022342309999999997	0.7888716477877847
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.022342309999999997	0.7888716477877847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.022342309999999997	0.7888716477877847
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.022237358999999998	0.7851659938823928
AYM-GRIPP SYNDROME	0.022081614	0.7796668841312208
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02207863	0.779561523808273
OPTIC ATROPHY 11; OPA11	0.022068624	0.7792082277655735
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02196784	0.7756497040430649
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7756429954434134
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02196306	0.7754809297992008
SIALURIA	0.021920273	0.7739701884661025
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.021920273	0.7739701884661025
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.7739701884661025
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.021822154	0.7705057616808109
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.021822154	0.7705057616808109
HUNTINGTON DISEASE; HD	0.021818019	0.7703597613673427
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.021818019	0.7703597613673427
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.021818019	0.7703597613673427
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021756653	0.7681930249135855
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653	0.7681930249135855
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.021546533	0.7607740198674121
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.021453503000000002	0.757489277627523
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.021444369	0.757166770526382
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.021436594	0.7568922475669588
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.7547075391278194
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.7547075391278194
CEREBROTENDINOUS XANTHOMATOSIS	0.021343319	0.7535988547643612
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.021343319	0.7535988547643612
GAUCHER DISEASE, PERINATAL LETHAL	0.021343308999999998	0.7535985016801688
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.021299298999999997	0.7520445781503664
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7515892760845451
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7512431123425277
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 69	0.0212766	0.7512431123425277
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.7512431123425277
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7512431123425277
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7512431123425277
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 1	0.0212766	0.7512431123425277
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7512431123425277
NEUROFERRITINOPATHY	0.0212766	0.7512431123425277
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7512431123425277
KURU, SUSCEPTIBILITY TO	0.0212766	0.7512431123425277
PRIMARY BASILAR INVAGINATION	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.7512431123425277
RETINITIS PIGMENTOSA 6	0.0212766	0.7512431123425277
KID SYNDROME	0.021106009999999998	0.7452198491080583
JOUBERT SYNDROME WITH OCULAR DEFECT	0.021083012999999998	0.7444078613912923
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.021000979000000003	0.7415113705291291
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7405732611389149
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7405732611389149
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.020937633	0.7392747234053193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.020937633	0.7392747234053193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020937633	0.7392747234053193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.020937633	0.7392747234053193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.020937633	0.7392747234053193
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.020928259999999997	0.7389437775919849
MENKES DISEASE	0.020903749000000003	0.7380783329285225
SECONDARY SHORT BOWEL SYNDROME	0.02089104	0.7376295982286757
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02089104	0.7376295982286757
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	0.7376295982286757
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7355908901030044
CRANDALL SYNDROME	0.0208333	0.7355908901030044
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7355908901030044
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7355908901030044
STICKLER SYNDROME, TYPE III	0.0208333	0.7355908901030044
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7355908901030044
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7355908901030044
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7355908901030044
GLAUCOMA - SLEEP APNEA	0.0208333	0.7355908901030044
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7355908901030044
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7355908901030044
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.7355908901030044
ACROMEGALY	0.0208333	0.7355908901030044
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7355908901030044
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7355908901030044
HYPOCHONDROPLASIA	0.0208333	0.7355908901030044
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7355908901030044
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7355908901030044
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7355908901030044
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7355908901030044
UNIQUE GREEN PHENOMENON	0.0208333	0.7355908901030044
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7355908901030044
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7355908901030044
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7355908901030044
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7355908901030044
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7355908901030044
DERMOIDS OF CORNEA	0.0208333	0.7355908901030044
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.7355908901030044
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.7355908901030044
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7355908901030044
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7355908901030044
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7355908901030044
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7355908901030044
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.7355908901030044
PUPIL, EGG-SHAPED	0.0208333	0.7355908901030044
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.7355908901030044
GAUCHER DISEASE, TYPE I	0.0208333	0.7355908901030044
IMINOGLYCINURIA	0.0208333	0.7355908901030044
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7355908901030044
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7355908901030044
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7355908901030044
611426 TENTED EYEBROWS	0.0208333	0.7355908901030044
APNEA, CENTRAL SLEEP	0.0208333	0.7355908901030044
SOMATOMAMMOTROPINOMA	0.0208333	0.7355908901030044
ALSTRM SYNDROME	0.020809673	0.734756658082131
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.020801899999999998	0.734482205739546
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.020762933	0.7331063425678622
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7323266267462618
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7323266267462618
8Q24.3 MICRODELETION SYNDROME	0.020670523000000003	0.7298434915478885
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.7298137265504875
SPINOCEREBELLAR ATAXIA TYPE 7	0.020648064	0.7290504997606622
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.020643039999999998	0.7288731102625087
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.020525164	0.7247110950387189
ANGELMAN SYNDROME	0.020427293000000003	0.7212554247413935
STEVENS-JOHNSON SYNDROME	0.02040596	0.720502190234207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020365924	0.7190885823623785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020304313999999997	0.7169132306543319
RETINITIS PIGMENTOSA 80; RP80	0.020268254	0.7156400090573158
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.020264119	0.7154940087438477
MIRAGE SYNDROME; MIRAGE	0.020222313000000002	0.7140179049700028
SMITH-FINEMAN-MYERS SYNDROME	0.020143929	0.7112502898379865
SIALIDOSIS TYPE 1	0.020139909	0.7111083499927284
GAUCHER DISEASE, TYPE II	0.020066143	0.7085037891406629
TRANSIENT NEONATAL DIABETES MELLITUS	0.019967994	0.7050383031027946
PERMANENT NEONATAL DIABETES MELLITUS	0.019967994	0.7050383031027946
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.019837683000000002	0.7004372276860238
DISTAL MONOSOMY 10Q	0.019744673	0.6971531916145189
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0197227	0.6963773597190327
6Q TERMINAL DELETION SYNDROME	0.019693442999999998	0.6953443412979595
LEUKOCYTE ADHESION DEFICIENCY	0.019676759000000002	0.6947552556317196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6947270442047639
PITT-HOPKINS-LIKE SYNDROME	0.019610859	0.692428430805226
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6919849923682618
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.019575273	0.6911719453989195
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.019502879	0.6886158276980215
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.019436834	0.6862838831507413
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.019234638999999998	0.6791446973268739
CONE-ROD DYSTROPHY 16	0.01919311	0.6776783739851524
CONE DYSTROPHY 3	0.01919311	0.6776783739851524
PYRIDOXINE-DEPENDENT EPILEPSY	0.019185074	0.6773946355283131
DYSEQUILIBRIUM SYNDROME	0.019142739	0.6758998536007015
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01913954	0.6757869019676219
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019099134	0.6743602299806826
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.6737589276013929
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01893494	0.6685627993955342
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.018912919	0.6677852726959255
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083000000002	0.6677204464382405
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01890171	0.6673895006249062
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.018842653	0.6653042913111243
OROFACIODIGITAL SYNDROME TYPE 6	0.018820813	0.664533155435394
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.018776583000000003	0.6629714640533637
GAUCHER DISEASE	0.01877383	0.6628742599752552
ZTTK SYNDROME; ZTTKS	0.018710703	0.6606453453952544
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6544962782631097
HYPERPROLINEMIA, TYPE I	0.018481163000000002	0.6525406508478595
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01846839	0.6520896564091827
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.01846839	0.6520896564091827
MOSAIC TRISOMY 15	0.01846839	0.6520896564091827
ALG11-CDG	0.018461303	0.6518394256421817
ALG3-CDG	0.018442962999999996	0.651191869233716
MULTIPLE CARBOXYLASE DEFICIENCY	0.018442962999999996	0.651191869233716
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018392944	0.6494257774128303
X SMALL RINGS	0.018296724	0.6460284013156342
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.018285753000000002	0.645641032648389
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.018285753000000002	0.645641032648389
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018285753000000002	0.645641032648389
NEONATAL ADRENOLEUKODYSTROPHY	0.018258609	0.6446826209171242
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0182192	0.6432911514241458
XYLOSIDASE DEFICIENCY	0.018209209000000004	0.6429383850077348
SALLA DISEASE	0.018158702999999998	0.6411550979866893
PREECLAMPSIA	0.018022939999999998	0.6363615210683397
FETAL PARVOVIRUS SYNDROME	0.018022939999999998	0.6363615210683397
LOEYS-DIETZ SYNDROME 5	0.01800905	0.6358710871253959
GERODERMA OSTEODYSPLASTICA	0.017901544	0.632075220208901
CONGENITAL HYPOTHYROIDISM	0.017901544	0.632075220208901
CHOREOACANTHOCYTOSIS	0.017897409	0.6319292198954328
MPDU1-CDG	0.017897408999999996	0.6319292198954327
BENIGN FAMILIAL INFANTILE EPILEPSY	0.017897408999999996	0.6319292198954327
CURRARINO SYNDROME	0.017786954	0.6280292284506629
WHIM SYNDROME	0.017782819000000002	0.6278832281371948
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.017782819000000002	0.6278832281371948
YUNIS-VARON SYNDROME	0.01770471	0.6251253228204635
COFFIN-SIRIS SYNDROME 1; CSS1	0.017626803	0.6223745498044144
PHELAN-MCDERMID SYNDROME	0.017580213	0.6207295305530286
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.017580213	0.6207295305530286
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.017580213	0.6207295305530286
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01752372	0.6187348520261227
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01752372	0.6187348520261227
STICKLER SYNDROME	0.017505430000000002	0.6180890610386178
MEHMO SYNDROME	0.017498359	0.6178393952063244
HYPEREKPLEXIA 2; HKPX2	0.01748359	0.6173179251628876
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.017404578999999996	0.6145281716520212
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.017374329999999997	0.6134601272790835
TOWNES-BROCKS SYNDROME	0.017374329999999997	0.6134601272790835
EEM SYNDROME	0.017374329999999997	0.6134601272790835
WAARDENBURG SYNDROME TYPE 1	0.017374329999999997	0.6134601272790835
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.017317623	0.6114578927504649
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.017289374000000003	0.610460465215964
ISOLATED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123797
RAT-BITE FEVER	0.0172414	0.6087665791123797
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6087665791123797
MELIOIDOSIS	0.0172414	0.6087665791123797
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.0172414	0.6087665791123797
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6087665791123797
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0172414	0.6087665791123797
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0172414	0.6087665791123797
TRANSSEXUALITY	0.0172414	0.6087665791123797
CYCLIC NEUTROPENIA	0.0172414	0.6087665791123797
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6087665791123797
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6087665791123797
269800 SENILE PLAQUE FORMATION	0.0172414	0.6087665791123797
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6087665791123797
X-LINKED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123797
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6087665791123797
PLAGUE	0.0172414	0.6087665791123797
FELTY SYNDROME	0.0172414	0.6087665791123797
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123797
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.0172414	0.6087665791123797
WISKOTT-ALDRICH SYNDROME	0.0172414	0.6087665791123797
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6087665791123797
LAMELLAR ICHTHYOSIS	0.0172414	0.6087665791123797
CERVICAL RIB	0.0172414	0.6087665791123797
NEUROLEPTIC MALIGNANT SYNDROME	0.0172414	0.6087665791123797
IMMUNODEFICIENCY 46; IMD46	0.0172414	0.6087665791123797
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6087665791123797
ALCOHOL DEPENDENCE	0.0172414	0.6087665791123797
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6087665791123797
HIRSCHSPRUNG DISEASE	0.0172414	0.6087665791123797
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0172414	0.6087665791123797
THUMBS, CONGENITAL CLASPED	0.0172414	0.6087665791123797
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6087665791123797
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0172414	0.6087665791123797
PYOMYOSITIS	0.0172414	0.6087665791123797
CHRONIC GRANULOMATOUS DISEASE	0.0172414	0.6087665791123797
OMENN SYNDROME	0.0172414	0.6087665791123797
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6087665791123797
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6087665791123797
RETICULAR DYSGENESIS	0.0172414	0.6087665791123797
SEVERE COMBINED IMMUNODEFICIENCY	0.0172414	0.6087665791123797
RETICULAR DYSGENESIA	0.0172414	0.6087665791123797
PALMOMENTAL REFLEX	0.0172414	0.6087665791123797
CLASSIC GALACTOSEMIA	0.0172414	0.6087665791123797
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6087665791123797
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6087665791123797
DIASTEMATOMYELIA	0.0172414	0.6087665791123797
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6087665791123797
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6087665791123797
MYOPATHY, CONGENITAL	0.0172414	0.6087665791123797
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6087665791123797
MOTION SICKNESS	0.0172414	0.6087665791123797
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6087665791123797
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6087665791123797
LEGIONELLOSIS	0.0172414	0.6087665791123797
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6087665791123797
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6087665791123797
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6087665791123797
BULLOUS IMPETIGO	0.0172414	0.6087665791123797
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6087665791123797
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6087665791123797
CALCIPHYLAXIS	0.0172414	0.6087665791123797
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6087665791123797
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0172414	0.6087665791123797
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6087665791123797
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6087665791123797
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6087665791123797
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6087665791123797
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6087665791123797
ACQUIRED PURPURA FULMINANS	0.0172414	0.6087665791123797
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6087665791123797
RADIATION PROCTITIS	0.0172414	0.6087665791123797
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6087665791123797
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6087665791123797
CARDIAC ARRHYTHMIA	0.0172414	0.6087665791123797
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6087665791123797
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6087665791123797
SICKLE CELL ANEMIA	0.0172414	0.6087665791123797
RECOMBINANT 8 SYNDROME	0.017215973	0.607868791936913
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.017198779999999997	0.6072617342852907
SOTOS SYNDROME 2	0.017198779999999997	0.6072617342852907
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.017098354	0.6037158509768623
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.017021764	0.601011579148924
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.017021764	0.601011579148924
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.01698294	0.5996407650811881
PHACE SYNDROME	0.016892593	0.5964507553300621
OROFACIODIGITAL SYNDROME TYPE 2	0.016847064000000002	0.5948431983114668
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.016712754	0.5901009245262415
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5901009245262415
FARBER DISEASE	0.016674553999999998	0.588752142912098
INSULINOMA	0.016670419	0.5886061425986299
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016670419	0.5886061425986299
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016670419	0.5886061425986299
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.016505993000000004	0.5828005204602229
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.016499004	0.5825537499183053
JACOBSEN SYNDROME	0.01647257	0.5816204071646857
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.016439163	0.5804408588038561
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.016439163	0.5804408588038561
FUMARASE DEFICIENCY; FMRD	0.016431404	0.5801669007791405
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016347039	0.5771881059917789
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.016334883	0.5767588968477599
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.016334883	0.5767588968477599
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.5755805489731836
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5755805489731836
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5755805489731836
STERNAL CLEFT	0.016128999999999998	0.5694894935738148
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.5694894935738148
DIPROSOPUS	0.016128999999999998	0.5694894935738148
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.5694894935738148
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.5694894935738148
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.5694894935738148
NARCOLEPSY TYPE 1	0.016128999999999998	0.5694894935738148
ARACHNOIDITIS	0.016128999999999998	0.5694894935738148
ACRORENAL SYNDROME	0.016128999999999998	0.5694894935738148
SILENT SINUS SYNDROME	0.016128999999999998	0.5694894935738148
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.5694894935738148
CENTRAL NEUROCYTOMA	0.016128999999999998	0.5694894935738148
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.5694894935738148
WAARDENBURG SYNDROME	0.016128999999999998	0.5694894935738148
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.5694894935738148
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.5694894935738148
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.5694894935738148
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.5694894935738148
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.5694894935738148
ALKAPTONURIA	0.016128999999999998	0.5694894935738148
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.016073459999999998	0.567528463970424
WITTEVEEN-KOLK SYNDROME	0.016047313	0.5666052547331203
FANCONI ANEMIA	0.015858393999999998	0.5599348234827964
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01579181	0.5575838476975575
CONGENITAL TOXOPLASMOSIS	0.015775823	0.5570193719995128
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.015742659000000003	0.5558484035845533
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5541652865488306
RING CHROMOSOME 14 SYNDROME	0.015689494	0.5539712314768062
AMISH LETHAL MICROCEPHALY	0.01567665	0.5535177301403649
DUANE RETRACTION SYNDROME	0.015665603	0.5531276780332591
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.015665603	0.5531276780332591
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.015665603	0.5531276780332591
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.015665603	0.5531276780332591
MUENKE SYNDROME	0.015665603	0.5531276780332591
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.015647262999999998	0.5524801216247933
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015592539999999998	0.550547938999904
KNOBLOCH SYNDROME	0.015485348999999997	0.5467631942354628
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015471144	0.5462616381404652
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5462549295408138
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5462549295408138
NEURAMINIDASE DEFICIENCY	0.015467008999999999	0.5461156378269971
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.015437559	0.5450758048810148
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.01541902	0.5444212220971247
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.01541902	0.5444212220971247
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.015415903	0.5443111657544208
SEVERE CANAVAN DISEASE	0.015251322999999999	0.538500106119454
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01522724	0.537649773459417
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5368438234823375
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.015193833	0.5364702250985874
MONOSOMY 22Q13.3	0.015090692999999999	0.5328285147404
NEMALINE MYOPATHY 2; NEM2	0.01507321	0.5322112176472046
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.015019133	0.5303018442611304
COHEN SYNDROME	0.015014439	0.530136106541319
LOWE OCULOCEREBRORENAL SYNDROME	0.015014439	0.530136106541319
1Q41Q42 MICRODELETION SYNDROME	0.015008108999999999	0.5299126042476665
OCULOECTODERMAL SYNDROME; OES	0.014990953	0.5293068530075553
REFSUM DISEASE	0.014925589999999999	0.5269989888021821
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.5269989888021821
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5269922802025306
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5269922802025306
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5269922802025306
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5269922802025306
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.014863314	0.5248001216869361
ADAMS-OLIVER SYNDROME	0.014863008999999998	0.5247893526190744
ADRENOLEUKODYSTROPHY	0.014829979	0.5236231155322904
DONNAI-BARROW SYNDROME	0.014785572999999998	0.5220552098684773
HSD10 DISEASE	0.014785572999999998	0.5220552098684773
RENPENNING SYNDROME 1; RENS1	0.014755289	0.5209859297008669
NEURONAL CEROID LIPOFUSCINOSIS	0.014705768999999999	0.5192374567811708
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.014668233000000001	0.5179121199573885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.014668233000000001	0.5179121199573885
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5175811741440544
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014648279	0.5172075757603043
DESMOSTEROLOSIS	0.014633569999999999	0.5166882242220205
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.014607759000000001	0.5157768786135741
MARSHALL SYNDROME	0.014578629999999999	0.5147483796701608
CROUZON DISEASE	0.014578629999999999	0.5147483796701608
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.014578629999999999	0.5147483796701608
BENCZE SYNDROME	0.014578629999999999	0.5147483796701608
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.014578629999999999	0.5147483796701608
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.014578629999999999	0.5147483796701608
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.014578629999999999	0.5147483796701608
MORNING GLORY DISC ANOMALY	0.014578629999999999	0.5147483796701608
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.014549274	0.5137118657155851
WEBB-DATTANI SYNDROME; WEDAS	0.014518483	0.5126246841794309
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.014514644	0.5124891351580514
ELEJALDE DISEASE	0.014509063	0.5122920788703934
RETINAL DYSTROPHY AND OBESITY; RDOB	0.014503519999999999	0.5120963643026657
LAND ISLANDS EYE DISEASE	0.014503519999999999	0.5120963643026657
EDICT SYNDROME	0.014503519999999999	0.5120963643026657
MEGALOCORNEA	0.014503519999999999	0.5120963643026657
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.014498680000000002	0.5119254715536486
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014477714	0.5111851952363153
RETT SYNDROME; RTT	0.014473579	0.5110391949228471
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.5094108059369131
CHDIAK-HIGASHI SYNDROME	0.014420272999999999	0.5091570443279904
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014420272999999999	0.5091570443279904
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.014394273	0.5082390254283117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5029385608436623
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5029385608436623
MEDULLOBLASTOMA	0.014244153999999998	0.5029385608436623
JOUBERT SYNDROME 35; JBTS35	0.014244153999999998	0.5029385608436623
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5029385608436623
SENIOR-LOKEN SYNDROME	0.014244153999999998	0.5029385608436623
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5029385608436623
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.014244153999999998	0.5029385608436623
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.014240018999999998	0.5027925605301942
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.014240018999999998	0.5027925605301942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.014234453	0.5025960338688245
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.014234319	0.5025913025406492
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.014163232999999999	0.5000813682520889
BRITTLE CORNEA SYNDROME	0.01407841	0.4970864022087253
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.01396909	0.49322648581976825
CRANIOFRONTONASAL SYNDROME; CFNS	0.013967644000000001	0.49317542984557844
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.013967644000000001	0.49317542984557844
2Q23.1 MICRODUPLICATION SYNDROME	0.013964454	0.4930627959882717
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.013963509	0.49302942953211026
16Q24.3 MICRODELETION SYNDROME	0.013960318999999999	0.4929167956748035
WRINKLY SKIN SYNDROME	0.013933794	0.4919802398550351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013933794	0.4919802398550351
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.013932159999999999	0.4919225458980321
CARNOSINASE DEFICIENCY	0.013932159999999999	0.4919225458980321
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013878854	0.49004039530317534
PFEIFFER SYNDROME TYPE 3	0.013874718999999999	0.48989439498970716
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.013874718999999999	0.48989439498970716
CLASSIC HOMOCYSTINURIA	0.013874718999999999	0.48989439498970716
QAZI-MARKOUIZOS SYNDROME	0.013867059	0.4896239324984941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.013867059	0.4896239324984941
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.013766914	0.48608797085586597
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.48367591150537914
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.48367591150537914
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.48367591150537914
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.48367591150537914
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.013698599999999998	0.48367591150537914
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.48367591150537914
ANIRIDIA 3	0.013698599999999998	0.48367591150537914
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.48367591150537914
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.48367591150537914
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.48367591150537914
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.48367591150537914
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.48367591150537914
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.48367591150537914
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.013698599999999998	0.48367591150537914
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.48367591150537914
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.48367591150537914
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.013698599999999998	0.48367591150537914
BEHR SYNDROME	0.013698599999999998	0.48367591150537914
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.48367591150537914
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.48367591150537914
BASAL LAMINAR DRUSEN	0.013698599999999998	0.48367591150537914
CHOROIDEREMIA	0.013698599999999998	0.48367591150537914
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.48367591150537914
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.48367591150537914
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.48367591150537914
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.48367591150537914
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.013688899	0.4833333845305413
MICRO SYNDROME	0.013641863	0.48167261772418396
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013510793	0.4770447432172263
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.013510793	0.4770447432172263
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.013450319	0.4749095018734119
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.013422090000000001	0.4739127805072953
X-LINKED RECESSIVE OCULAR ALBINISM	0.0134189	0.4738001466499885
OCULAR ALBINISM	0.0134189	0.4738001466499885
PELIZAEUS-MERZBACHER DISEASE	0.013336329000000001	0.47088469516670484
CATARACT 17, MULTIPLE TYPES	0.0133333	0.4707777459648922
SPONDYLOOCULAR SYNDROME; SOS	0.0133333	0.4707777459648922
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.4707777459648922
ISOLATED ECTOPIA LENTIS	0.0133333	0.4707777459648922
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.4707777459648922
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.4707777459648922
CORNELIA DE LANGE SYNDROME	0.013311039	0.4699917452446711
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013285183999999998	0.4690788460657788
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.013282073	0.46896900157359045
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013282073	0.46896900157359045
SHUKLA-VERNON SYNDROME; SHUVER	0.013282073	0.46896900157359045
PERLMAN SYNDROME	0.013266844	0.46843128965731323
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.013233033	0.46723747669511934
CHROMOSOME 5Q12 DELETION SYNDROME	0.013211193000000001	0.4664663408193892
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013211193000000001	0.4664663408193892
COG5-CDG	0.013114648999999999	0.4630575247943665
TAY-SACHS DISEASE	0.013010963000000002	0.4593965360392861
CANAVAN DISEASE	0.013010963	0.459396536039286
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.012993253	0.4587712239349278
SCHINDLER DISEASE, TYPE I	0.012993253	0.4587712239349278
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.012993253	0.4587712239349278
KRABBE DISEASE	0.012969374	0.4579280941924113
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.012921609	0.4562415875484437
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012856194000000001	0.4539318873052711
JOUBERT SYNDROME WITH RENAL DEFECT	0.012818553	0.4526028430974707
48,XXYY SYNDROME	0.012818553	0.4526028430974707
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012818553	0.4526028430974707
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012818553	0.4526028430974707
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012818553	0.4526028430974707
JOUBERT SYNDROME	0.012818553	0.4526028430974707
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01276962	0.4508750962198561
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.012749003000000002	0.45014714254083005
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.4498523525487755
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012740654	0.4498523525487755
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012740654	0.4498523525487755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012740654	0.4498523525487755
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.4498523525487755
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012736519	0.4497063522353073
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.012730663000000001	0.44949958613236435
EPIDERMAL NEVUS SYNDROME	0.012719124	0.44909216228300297
CORNELIA DE LANGE SYNDROME 1	0.012689699	0.4480532120475011
RING CHROMOSOME 12 SYNDROME	0.012669774000000002	0.44734969179457423
JACOBSEN SYNDROME	0.012629603	0.4459313172861512
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012621729	0.4456532987932254
TEMPLE-BARAITSER SYNDROME	0.012621729	0.4456532987932254
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.012515993	0.4419199277787471
KRABBE DISEASE	0.012465409000000002	0.4401338867010029
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.012459654	0.43993068674840086
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.012441302999999999	0.4392827419473237
HELSMOORTEL-VAN DER AA SYNDROME	0.012441302999999999	0.4392827419473237
MICROPHTHALMIA, ISOLATED 5	0.01243895	0.43919966123690285
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01243895	0.43919966123690285
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01242382	0.4386654448541282
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012395432999999999	0.43766314475777496
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012358718999999999	0.4363668314545901
4Q21 MICRODELETION SYNDROME	0.012315089	0.43482632512409064
TARP SYNDROME	0.012240173	0.43218115958992387
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.43058970321049234
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.43058970321049234
LELIS SYNDROME	0.0121951	0.43058970321049234
FACIOCARDIOMELIC SYNDROME	0.0121951	0.43058970321049234
JUBERG-MARSIDI SYNDROME	0.0121951	0.43058970321049234
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.43058970321049234
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0121951	0.43058970321049234
CATARACT 48; CTRCT48	0.0121951	0.43058970321049234
RHYNS SYNDROME; RHYNS	0.0121951	0.43058970321049234
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.43058970321049234
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.43058970321049234
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0121951	0.43058970321049234
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.43058970321049234
LOEYS-DIETZ SYNDROME 3; LDS3	0.0121951	0.43058970321049234
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01217357	0.4298295129447198
LOWRY-WOOD SYNDROME	0.01217357	0.4298295129447198
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012144022999999999	0.42878625508207324
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012084049	0.42666866794786806
MICROFORM HOLOPROSENCEPHALY	0.012084049	0.42666866794786806
ROIFMAN SYNDROME; RFMN	0.012069844000000001	0.4261671118528706
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.012045363	0.42530272644198447
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.42510821236051016
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.42510821236051016
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.42510821236051016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.42510821236051016
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.012026884	0.4246502621632474
PITT-HOPKINS SYNDROME	0.012022749	0.4245042618497792
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011962653	0.4223823670884294
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.011959423	0.4222683208943539
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.011823753	0.41747802765899156
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.011766262999999999	0.41544814663812485
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011766262999999999	0.41544814663812485
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011766262999999999	0.41544814663812485
SHPRINTZEN-GOLDBERG SYNDROME	0.01173158	0.41422354473437256
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.011639140000000001	0.41095963446182227
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011591563	0.4092797658006677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.011591563	0.4092797658006677
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.011573223	0.408632209392202
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.011573223	0.408632209392202
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.011573223	0.408632209392202
DIAMOND-BLACKFAN ANEMIA 1	0.01154263	0.40755201892305304
2P15P16.1 MICRODELETION SYNDROME	0.011522284	0.4068336338256352
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.4067039106934268
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.4067039106934268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.4061765088355613
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.4061765088355613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.4061765088355613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011503673	0.4061765088355613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.4061765088355613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.4061765088355613
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.4061765088355613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.4061765088355613
PEHO SYNDROME; PEHO	0.011503673	0.4061765088355613
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.011503673	0.4061765088355613
HYPEREKPLEXIA 4; HKPX4	0.011503673	0.4061765088355613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.4061765088355613
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.405845563022227
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.405845563022227
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.405845563022227
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.405845563022227
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011455493	0.40447534919761813
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.011448504	0.40422857865570055
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.40354062941564894
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011384273	0.4019606835808825
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011384273	0.4019606835808825
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011384273	0.4019606835808825
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011384273	0.4019606835808825
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011341312999999999	0.4004438338912594
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.011341312999999999	0.4004438338912594
DESANTO-SHINAWI SYNDROME	0.011341312999999999	0.4004438338912594
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0113107	0.39936293725372607
DUBOWITZ SYNDROME	0.0113107	0.39936293725372607
KOOLEN-DE VRIES SYNDROME; KDVS	0.011170682999999999	0.3944191583200213
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0111532	0.39380186122682576
PRIMARY PULMONARY HYPOPLASIA	0.0111532	0.39380186122682576
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.011113389	0.3923961977493214
JOUBERT SYNDROME 21	0.011050144	0.39016311677585275
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011031804	0.389515560367387
RETT SYNDROME, CONGENITAL VARIANT	0.011028268999999999	0.38939074510544985
HYPOPHOSPHATASIA, INFANTILE	0.011027669	0.38936956005391893
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.011027669	0.38936956005391893
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010973033	0.38744044926150156
PIERPONT SYNDROME	0.010966703	0.387216946967849
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.010962254000000001	0.3870598598107463
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.38691385949727813
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.38691385949727813
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.010958119	0.38691385949727813
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010958119	0.38691385949727813
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.38691385949727813
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.38691385949727813
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.38691385949727813
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010958119	0.38691385949727813
ISOLATED COMPLEX I DEFICIENCY	0.010935914000000001	0.38612983604853324
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01090295	0.38496592931741735
MUSCLE-EYE-BRAIN DISEASE	0.010851199	0.3831386833144452
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010842854	0.3828440345560675
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010842854	0.3828440345560675
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.010842854	0.3828440345560675
PEDIATRIC-ONSET GRAVES DISEASE	0.010842854	0.3828440345560675
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.010799893999999999	0.3813271848664444
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.010799893999999999	0.3813271848664444
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.010799893999999999	0.3813271848664444
BARDET-BIEDL SYNDROME 1; BBS1	0.010799893999999999	0.3813271848664444
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.010799893999999999	0.3813271848664444
9Q33.3Q34.11 MICRODELETION SYNDROME	0.010795758999999999	0.3811811845529762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010788543000000001	0.3809263989998962
ADAMS-OLIVER SYNDROME 1; AOS1	0.010788543000000001	0.3809263989998962
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.010788543000000001	0.3809263989998962
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.010777419	0.3805336281445105
INFANTILE SIALIC ACID STORAGE DISEASE	0.010717323	0.3784117333831607
20P13 MICRODELETION SYNDROME	0.010708829	0.3781118236703194
COCKAYNE SYNDROME A; CSA	0.010625128999999999	0.3751565089817381
WOLCOTT-RALLISON SYNDROME	0.010606789	0.3745089525732724
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.010578423	0.37350739395372284
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.010550563	0.3725237013942978
DISTAL MONOSOMY 10P	0.01054668	0.37238659880247266
MONOSOMY 5P	0.01052834	0.37173904239400696
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01052834	0.37173904239400696
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.010520933	0.37147751293285614
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010520933	0.37147751293285614
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010520933	0.37147751293285614
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010520933	0.37147751293285614
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010520933	0.37147751293285614
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.010520933	0.37147751293285614
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010520933	0.37147751293285614
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010520933	0.37147751293285614
GAUCHER DISEASE TYPE 3	0.01050459	0.3709004674375696
CAMPOMELIC DYSPLASIA	0.01048625	0.3702529110291039
STUVE-WIEDEMANN SYNDROME	0.01048625	0.3702529110291039
GENITOPATELLAR SYNDROME	0.010346233	0.36530913209539906
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010346233	0.36530913209539906
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010346233	0.36530913209539906
PROPIONIC ACIDEMIA	0.010346233	0.36530913209539906
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.010346233	0.36530913209539906
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.010346233	0.36530913209539906
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.36530913209539906
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010346233	0.36530913209539906
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.010346233	0.36530913209539906
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0102973	0.3635813852177844
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0102973	0.3635813852177844
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.0102973	0.3635813852177844
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0102973	0.3635813852177844
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0102973	0.3635813852177844
RESTRICTIVE DERMOPATHY, LETHAL	0.0102973	0.3635813852177844
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0102973	0.3635813852177844
PEMPHIGOID GESTATIONIS	0.0102973	0.3635813852177844
VACTERL/VATER ASSOCIATION	0.0102973	0.3635813852177844
TEMPLE SYNDROME	0.0102973	0.3635813852177844
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.010254339999999999	0.36206453552816126
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.010254339999999999	0.36206453552816126
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010254339999999999	0.36206453552816126
BRANCHIOGENIC DEAFNESS SYNDROME	0.010254339999999999	0.36206453552816126
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010247124000000002	0.3618097499750812
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.010247124000000002	0.3618097499750812
OROFACIODIGITAL SYNDROME VI	0.010247124000000002	0.3618097499750812
ERMINE PHENOTYPE	0.010236	0.36141697911969556
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.010215159	0.3606811163547645
MICROPHTHALMIA, SYNDROMIC 1	0.010215159	0.3606811163547645
GAPO SYNDROME; GAPOS	0.010109288999999999	0.35694301401211087
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.010095983	0.3564732001859907
16P12.1P12.3 TRIPLICATION SYNDROME	0.01008371	0.3560398599569231
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010065483	0.35539629339982903
MULTIPLE SULFATASE DEFICIENCY	0.010065483	0.35539629339982903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.010065483	0.35539629339982903
1Q44 MICRODELETION SYNDROME	0.010060124	0.3552070755812376
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.009979514	0.35236086390804117
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009975379	0.352214863594573
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.009975379	0.352214863594573
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009975379	0.352214863594573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009962314	0.3517535590974844
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.009958179	0.3516075587840162
CHROMOSOME 1P35 DELETION SYNDROME	0.009925353	0.35044852461475257
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0099044	0.34970870730686915
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.0099044	0.34970870730686915
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.009842769	0.347532614122019
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009842769	0.347532614122019
SECKEL SYNDROME 7; SCKL7	0.009842769	0.347532614122019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3461924830705841
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3461924830705841
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009804814	0.3461924830705841
OROFACIODIGITAL SYNDROME XVI; OFD16	0.009804814	0.3461924830705841
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3461924830705841
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3461924830705841
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3461924830705841
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.3461924830705841
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3461924830705841
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.3461924830705841
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3461924830705841
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009804814	0.3461924830705841
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3461924830705841
TENORIO SYNDROME; TNORS	0.009800679	0.3460464827571159
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.3460464827571159
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.009800679	0.3460464827571159
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.3460464827571159
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.3460464827571159
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.009800679	0.3460464827571159
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3460464827571159
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.3460464827571159
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.009800679	0.3460464827571159
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3460464827571159
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00971991	0.34319465704526375
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00967374	0.34156446732994955
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.3400324350200626
CLASSICAL EHLERS-DANLOS SYNDROME	0.009630350000000001	0.3400324350200626
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.3400324350200626
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009605869	0.33916804960917646
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.009583393	0.3383744575788234
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009561553	0.33760332170309326
PMM2-CDG	0.009561553	0.33760332170309326
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009561553	0.33760332170309326
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009561553	0.33760332170309326
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009561553	0.33760332170309326
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009561553	0.33760332170309326
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009561553	0.33760332170309326
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009561553	0.33760332170309326
OKAMOTO SYNDROME	0.009554564	0.3373565511611757
PEROXISOME BIOGENESIS DISORDER 5B	0.009524064	0.33627964437501406
PEROXISOME BIOGENESIS DISORDER 6B	0.009524064	0.33627964437501406
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009524064	0.33627964437501406
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00951457	0.33594442624295445
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.009509789999999999	0.3357756519990904
NANCE-HORAN SYNDROME	0.009509789999999999	0.3357756519990904
15Q OVERGROWTH SYNDROME	0.009494639	0.3352406941395122
KAGAMI-OGATA SYNDROME	0.009490333	0.3350886560863577
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3350886560863577
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3350886560863577
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.3350886560863577
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3350886560863577
KAGAMI-OGATA SYNDROME	0.009490333	0.3350886560863577
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.333098214569758
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.333098214569758
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00943396	0.333098214569758
POSTERIOR CORTICAL ATROPHY	0.00943396	0.333098214569758
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009383934	0.33133187558993754
SRD5A3-CDG	0.009351433	0.3301843166569199
PFEIFFER SYNDROME TYPE 2	0.009351433	0.3301843166569199
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009351433	0.3301843166569199
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009276742999999999	0.3275471308254964
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.009276742999999999	0.3275471308254964
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3269298337323009
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00925926	0.3269298337323009
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00925926	0.3269298337323009
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.3269298337323009
AORTIC ARCH DEFECTS	0.00925926	0.3269298337323009
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.3269298337323009
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00925926	0.3269298337323009
PAINE SYNDROME	0.00925926	0.3269298337323009
GLYCINE ENCEPHALOPATHY	0.00925926	0.3269298337323009
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.3269298337323009
LARYNGOTRACHEAL ANGIOMA	0.00925926	0.3269298337323009
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3269298337323009
HYDROXYLYSINURIA	0.00925926	0.3269298337323009
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3269298337323009
BUTYRYLCHOLINESTERASE	0.00925926	0.3269298337323009
MERRF	0.00925926	0.3269298337323009
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.3269298337323009
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3269298337323009
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3269298337323009
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.3269298337323009
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3269298337323009
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00925926	0.3269298337323009
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3269298337323009
CARNOSINEMIA	0.00925926	0.3269298337323009
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.3269298337323009
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009194158999999999	0.3246312203327628
INTELLECTUAL DISABILITY, WOLFF TYPE	0.009194158999999999	0.3246312203327628
21Q22.11Q22.12 MICRODELETION SYNDROME	0.009194158999999999	0.3246312203327628
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.009194158999999999	0.3246312203327628
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.009194158999999999	0.3246312203327628
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.32443705933548084
CHROMOSOME XP11.3 DELETION SYNDROME	0.009188660000000001	0.32443705933548084
HENNEKAM-BEEMER SYNDROME	0.009175819	0.3239836639242971
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.009175819	0.3239836639242971
ADRENOMYODYSTROPHY	0.009175819	0.3239836639242971
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.3239836639242971
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.009146503	0.3229485623064901
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00914415	0.32286548159606915
COLOBOMA, OCULAR	0.00914415	0.32286548159606915
GM1 GANGLIOSIDOSIS	0.009037839	0.31911180824054025
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.009020134	0.31848667267827824
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.31848667267827824
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.31848667267827824
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.31848667267827824
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009015999	0.31834067236481006
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.009015999	0.31834067236481006
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009015999	0.31834067236481006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009015999	0.31834067236481006
PACHYGYRIA, FRONTOTEMPORAL	0.009015999	0.31834067236481006
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.31834067236481006
SIFRIM-HITZ-WEISS SYNDROME	0.00900901	0.31809390182289254
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.31809390182289254
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.31809390182289254
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00900901	0.31809390182289254
HYDRANENCEPHALY	0.009005013000000001	0.3179527740712766
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00897851	0.3170169950367309
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.3159720070615427
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3159720070615427
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.3159720070615427
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.31582600674807454
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.31582600674807454
OLIVER SYNDROME	0.00893619	0.3155227427354076
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008924433	0.3151076216506567
MILLER-DIEKER SYNDROME	0.008863959	0.3129723803068422
FONTAINE PROGEROID SYNDROME; FPS	0.00883838	0.3120692262516544
PELGER-HUET ANOMALY; PHA	0.008833134	0.3118839982844346
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.008810014	0.31106766763210486
ECTODERMAL DYSPLASIA SYNDROME	0.008805878999999999	0.3109216673186367
KNOBLOCH SYNDROME 1; KNO1	0.008805878999999999	0.3109216673186367
TYROSINEMIA TYPE 2	0.008805878999999999	0.3109216673186367
GLIOBLASTOMA	0.008805878999999999	0.3109216673186367
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.008805878999999999	0.3109216673186367
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.008805878999999999	0.3109216673186367
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.008794863	0.3105327097725266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008735324	0.3084304818006814
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.008735324	0.3084304818006814
AARSKOG-SCOTT SYNDROME	0.008735324	0.3084304818006814
COFFIN-SIRIS SYNDROME 7; CSS7	0.008735324	0.3084304818006814
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.008735324	0.3084304818006814
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008735324	0.3084304818006814
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008735324	0.3084304818006814
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.008731188999999999	0.3082844814872132
MENTAL RETARDATION, X-LINKED 1	0.008731188999999999	0.3082844814872132
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.008716984	0.30778292539221574
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.008716984	0.30778292539221574
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.3057380736016004
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.3057380736016004
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.3057380736016004
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00865907	0.3057380736016004
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.3057380736016004
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.3057380736016004
CONE DYSTROPHY 4	0.00865907	0.3057380736016004
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.3057380736016004
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.008652739999999999	0.30551457130794785
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.30551457130794785
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.2999232359657773
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.2999232359657773
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.2999232359657773
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.2999232359657773
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.29922402333999504
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00847458	0.29922402333999504
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.29922402333999504
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.29922402333999504
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.29922402333999504
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.29922402333999504
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.29922402333999504
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.29922402333999504
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.29922402333999504
TUFTED ANGIOMA	0.00847458	0.29922402333999504
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00847458	0.29922402333999504
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.29670935772325957
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.29670935772325957
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.29670935772325957
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.29670935772325957
NEMALINE MYOPATHY 10	0.00840336	0.29670935772325957
SCHISIS ASSOCIATION	0.00840336	0.29670935772325957
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.29670935772325957
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.29670935772325957
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.29670935772325957
DISTAL MONOSOMY 17Q	0.00840336	0.29670935772325957
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.29670935772325957
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.29670935772325957
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.29670935772325957
HYDROLETHALUS	0.00840336	0.29670935772325957
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.29670935772325957
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.29670935772325957
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.29670935772325957
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.29670935772325957
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.29670935772325957
EBSTEIN MALFORMATION	0.00840336	0.29670935772325957
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.29670935772325957
TEMPLE SYNDROME	0.00840336	0.29670935772325957
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.29670935772325957
FATCO SYNDROME	0.00840336	0.29670935772325957
GMS SYNDROME	0.00840336	0.29670935772325957
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.29670935772325957
OMPHALOCELE	0.00840336	0.29670935772325957
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.29670935772325957
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.29670935772325957
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.29670935772325957
HEC SYNDROME	0.00840336	0.29670935772325957
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.29670935772325957
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.29670935772325957
RENAL TUBULAR DYSGENESIS	0.00840336	0.29670935772325957
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.29670935772325957
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.29670935772325957
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.29670935772325957
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.29670935772325957
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.29670935772325957
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.29670935772325957
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.29670935772325957
FOUNTAIN SYNDROME	0.008378879	0.29584497231237356
FLYNN-AIRD SYNDROME	0.008378879	0.29584497231237356
CADASIL	0.008378879	0.29584497231237356
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.008356403	0.29505138028202044
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.008338063000000001	0.29440382387355474
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.008338063000000001	0.29440382387355474
GM2-GANGLIOSIDOSIS, AB VARIANT	0.008338063000000001	0.29440382387355474
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.008335249	0.29430446598187404
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00828627	0.2925750949169753
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.29180501829382166
VON HIPPEL-LINDAU DISEASE	0.00826446	0.29180501829382166
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.29180501829382166
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.29180501829382166
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00826446	0.29180501829382166
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.29180501829382166
NEUROMYELITIS OPTICA	0.00826446	0.29180501829382166
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.29180501829382166
SPONDYLO-OCULAR SYNDROME	0.00826446	0.29180501829382166
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.29180501829382166
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.29180501829382166
BLAU SYNDROME	0.00826446	0.29180501829382166
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.29180501829382166
CUSHING DISEASE	0.00826446	0.29180501829382166
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.29180501829382166
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.29180501829382166
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00826446	0.29180501829382166
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.29180501829382166
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.29180501829382166
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00826446	0.29180501829382166
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00826446	0.29180501829382166
NANCE-HORAN SYNDROME	0.00826446	0.29180501829382166
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00826446	0.29180501829382166
WEILL-MARCHESANI SYNDROME	0.00826446	0.29180501829382166
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.29180501829382166
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.29180501829382166
X-LINKED CORNEAL DERMOID	0.00826446	0.29180501829382166
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.29180501829382166
CATARACT 44; CTRCT44	0.00826446	0.29180501829382166
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00826446	0.29180501829382166
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.29180501829382166
LCAT DEFICIENCY	0.00826446	0.29180501829382166
ISOLATED ANIRIDIA	0.00826446	0.29180501829382166
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.29180501829382166
BRITTLE CORNEA SYNDROME	0.00826446	0.29180501829382166
STICKLER SYNDROME TYPE 1	0.00826446	0.29180501829382166
CONGENITAL GLAUCOMA	0.00826446	0.29180501829382166
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.008249309	0.29127006043424347
DILATED CARDIOMYOPATHY WITH ATAXIA	0.008249309	0.29127006043424347
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008249309	0.29127006043424347
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.008232193	0.2906657215309011
HARTNUP DISEASE	0.008232193	0.2906657215309011
SMITH-MAGENIS SYNDROME	0.008232193	0.2906657215309011
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.008189769999999999	0.28916783246239824
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.008189769999999999	0.28916783246239824
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.008189769999999999	0.28916783246239824
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.008189769999999999	0.28916783246239824
FLOATING-HARBOR SYNDROME	0.008189769999999999	0.28916783246239824
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.008189769999999999	0.28916783246239824
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008146253000000001	0.2876313159832705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.008146253	0.2876313159832705
CONGENITAL RUBELLA SYNDROME	0.008072239	0.28501799864323873
MAN1B1-CDG	0.008031413	0.2835764971202277
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.28080658694096233
300270 ADRENOMYODYSTROPHY	0.007952964	0.28080658694096233
CROME SYNDROME	0.007948829	0.28066058662749416
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.28066058662749416
HALL-RIGGS SYNDROME	0.007948829	0.28066058662749416
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.28066058662749416
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.28066058662749416
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.28066058662749416
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.28066058662749416
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.28066058662749416
LISSENCEPHALY 5; LIS5	0.007948829	0.28066058662749416
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.28066058662749416
8P INVERTED DUPLICATION/DELETION SYNDROME	0.007948829	0.28066058662749416
FRYNS SYNDROME	0.007948829	0.28066058662749416
HEART AND BRAIN MALFORMATION SYNDROME	0.007901173000000001	0.27897792860122145
BONNEMANN-MEINECKE-REICH SYNDROME	0.00783746	0.2767283232875585
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007826813	0.27635239454814003
MOMO SYNDROME	0.007810849000000002	0.27578873094373735
ARIMA SYNDROME	0.007796644000000001	0.2752871748487397
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.007796644000000001	0.2752871748487397
JOUBERT SYNDROME 6	0.007796644000000001	0.2752871748487397
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.007792509000000001	0.2751411745352716
TRISOMY 18P	0.00770789	0.2721534114094285
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00770789	0.2721534114094285
6Q16 MICRODELETION SYNDROME	0.007690774	0.27154907250608606
ANGELMAN SYNDROME	0.007686639	0.27140307219261794
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007686639	0.27140307219261794
KABUKI SYNDROME	0.007686639	0.27140307219261794
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0076048339999999996	0.2685146669584555
MALAN OVERGROWTH SYNDROME	0.007600699000000001	0.2683686666449874
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2679133645791659
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2679133645791659
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2679133645791659
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2679133645791659
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2679133645791659
HYPOTONIA-CYSTINURIA SYNDROME	0.007586494	0.2678671105499898
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.26776736426569775
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.26776736426569775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007489994	0.26445984809541273
JOUBERT SYNDROME 24	0.007489994	0.26445984809541273
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007489994	0.26445984809541273
IMMUNODEFICIENCY 47	0.007485858999999999	0.26431384778194456
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007485858999999999	0.26431384778194456
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.26154393760267913
TRISOMY XQ28	0.00740741	0.26154393760267913
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.26154393760267913
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.26154393760267913
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.26154393760267913
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.26154393760267913
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.26154393760267913
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.26154393760267913
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007390803	0.2609575706847189
ABLEPHARON MACROSTOMIA SYNDROME	0.007359754	0.25986127957640637
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.007285394000000001	0.25723574552332507
VITREORETINOCHOROIDOPATHY; VRCP	0.007269430000000001	0.2566720819189223
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.007269430000000001	0.2566720819189223
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.007269430000000001	0.2566720819189223
PIERSON SYNDROME	0.007251090000000001	0.25602452551045657
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.007251090000000001	0.25602452551045657
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.007251090000000001	0.25602452551045657
EHLERS-DANLOS SYNDROME, TYPE VI	0.007251090000000001	0.25602452551045657
RECOMBINANT CHROMOSOME 8 SYNDROME	0.007208933000000001	0.25453602848146584
MUCOLIPIDOSIS TYPE IV	0.00714522	0.2522864231678029
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.007111073000000001	0.2510807465767517
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007111073000000001	0.2510807465767517
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.007111073000000001	0.2510807465767517
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007111073000000001	0.2510807465767517
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.007111073000000001	0.2510807465767517
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.0071082590000000005	0.25098138868507114
BANGSTAD SYNDROME	0.0071082590000000005	0.25098138868507114
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00705928	0.24925201762017235
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.24865071524088275
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.24865071524088275
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.24865071524088275
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.24865071524088275
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.24865071524088275
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.24865071524088275
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.24865071524088275
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.24865071524088275
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.24865071524088275
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.24865071524088275
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.24865071524088275
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.24865071524088275
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.24865071524088275
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.24865071524088275
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.24865071524088275
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.24865071524088275
SCHIZENCEPHALY	0.007005203	0.2473426442340981
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.007005203	0.2473426442340981
KBG SYNDROME	0.007005203	0.2473426442340981
ISOLATED GLYCEROL KINASE DEFICIENCY	0.006986862999999999	0.24669508782563238
VICI SYNDROME	0.006986862999999999	0.24669508782563238
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.006986862999999999	0.24669508782563238
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.006986862999999999	0.24669508782563238
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.006986862999999999	0.24669508782563238
CRANIOECTODERMAL DYSPLASIA 4	0.00694444	0.2451971987571296
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.2451971987571296
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00694444	0.2451971987571296
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00694444	0.2451971987571296
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00694444	0.2451971987571296
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00694444	0.2451971987571296
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00694444	0.2451971987571296
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00694444	0.2451971987571296
BRACHYDACTYLY, TYPE B2	0.00694444	0.2451971987571296
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00694444	0.2451971987571296
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00694444	0.2451971987571296
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.006900923	0.2436606822780018
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006900923	0.2436606822780018
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006900923	0.2436606822780018
XQ28 (MECP2) DUPLICATION	0.006900923	0.2436606822780018
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.006900923	0.2436606822780018
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.006900923	0.2436606822780018
TETRASOMY 5P	0.006900923	0.2436606822780018
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006900923	0.2436606822780018
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006849384	0.24184092165990392
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.006845248999999999	0.24169492134643575
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.006831044	0.24119336525143817
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006826909	0.24104736493797005
CHYLOMICRON RETENTION DISEASE	0.006814199999999999	0.24059863023812322
INTESTINAL LYMPHANGIECTASIA	0.006814199999999999	0.24059863023812322
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.006814199999999999	0.24059863023812322
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00673984	0.23797309618504187
SPINOCEREBELLAR ATAXIA TYPE 25	0.00673984	0.23797309618504187
RETINOBLASTOMA	0.00673984	0.23797309618504187
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00673984	0.23797309618504187
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00673984	0.23797309618504187
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00673984	0.23797309618504187
LEBER CONGENITAL AMAUROSIS 16	0.00673984	0.23797309618504187
FOCAL DERMAL HYPOPLASIA; FDH	0.00673984	0.23797309618504187
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00673984	0.23797309618504187
INCONTINENTIA PIGMENTI	0.006723853	0.2374086204869971
CYCLIC VOMITING SYNDROME	0.0066633790000000005	0.2352733791431827
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.006581483000000001	0.23238176084287138
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.006581483	0.23238176084287135
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006569654000000001	0.23196409755193675
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006569654000000001	0.23196409755193675
LIGNEOUS CONJUNCTIVITIS	0.006569654000000001	0.23196409755193675
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.006569654000000001	0.23196409755193675
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006569654000000001	0.23196409755193675
BEHET DISEASE	0.0065655190000000006	0.23181809723846858
SANDHOFF DISEASE	0.0065655190000000006	0.23181809723846858
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0065655190000000006	0.23181809723846858
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.0065655190000000006	0.23181809723846858
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0065655190000000006	0.23181809723846858
TAY-SACHS DISEASE; TSD	0.0065655190000000006	0.23181809723846858
COCKAYNE SYNDROME	0.006459649	0.22807999489581496
XERODERMA PIGMENTOSUM	0.006459649	0.22807999489581496
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.006459649	0.22807999489581496
PRIMARY CUTIS VERTICIS GYRATA	0.006459649	0.22807999489581496
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.006441308999999999	0.22743243848734923
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.006441308999999999	0.22743243848734923
ALAZAMI-YUAN SYNDROME	0.006359504	0.22454403325318684
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.006359504	0.22454403325318684
ZEBRA BODY MYOPATHY	0.006359504	0.22454403325318684
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.006359504	0.22454403325318684
HARTSFIELD SYNDROME; HRTFDS	0.006359504	0.22454403325318684
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.006359504	0.22454403325318684
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.006359504	0.22454403325318684
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006359504	0.22454403325318684
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006355369	0.22439803293971866
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.006355369	0.22439803293971866
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.006355369	0.22439803293971866
47,XYY SYNDROME	0.006355369	0.22439803293971866
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006355369	0.22439803293971866
MUCOLIPIDOSIS IV; ML4	0.006182434	0.21829197146218207
COFFIN-SIRIS SYNDROME 4; CSS4	0.006145473	0.21698693697945023
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006145473	0.21698693697945023
COFFIN-SIRIS SYNDROME 3; CSS3	0.006145473	0.21698693697945023
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.006145473	0.21698693697945023
SENGERS SYNDROME	0.00612196	0.21615673011836767
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00612196	0.21615673011836767
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.006040064	0.21326511181805635
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006040064	0.21326511181805635
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.006040064	0.21326511181805635
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006035929000000001	0.21311911150458823
EPISODIC ATAXIA TYPE 6	0.006035929000000001	0.21311911150458823
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006035929000000001	0.21311911150458823
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.006035929000000001	0.21311911150458823
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006035929000000001	0.21311911150458823
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.2127014482136536
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.2127014482136536
FRASER SYNDROME	0.006024100000000001	0.2127014482136536
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.2127014482136536
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.2127014482136536
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.2127014482136536
CYSTINOSIS, NEPHROPATHIC; CTNS	0.006024100000000001	0.2127014482136536
FLECK RETINA OF KANDORI	0.006024100000000001	0.2127014482136536
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.2127014482136536
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.2127014482136536
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.006024100000000001	0.2127014482136536
SANDHOFF DISEASE	0.006024100000000001	0.2127014482136536
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.2127014482136536
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.2127014482136536
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.2127014482136536
TEMPORAL ARTERITIS	0.006024100000000001	0.2127014482136536
MUSK, INABILITY TO SMELL	0.006024100000000001	0.2127014482136536
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.2127014482136536
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.2127014482136536
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.006024100000000001	0.2127014482136536
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.2127014482136536
WEILL-MARCHESANI SYNDROME 1; WMS1	0.006024100000000001	0.2127014482136536
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.2127014482136536
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.2127014482136536
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.006024100000000001	0.2127014482136536
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.2127014482136536
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.2127014482136536
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.2127014482136536
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.2127014482136536
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.2127014482136536
RETINITIS PIGMENTOSA	0.006024100000000001	0.2127014482136536
ALBERS-SCHNBERG OSTEOPETROSIS	0.006024100000000001	0.2127014482136536
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.2127014482136536
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.2127014482136536
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.2127014482136536
RODRIGUES BLINDNESS	0.006024100000000001	0.2127014482136536
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.2127014482136536
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.2127014482136536
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.2127014482136536
SARCOIDOSIS	0.006024100000000001	0.2127014482136536
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.2127014482136536
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.2127014482136536
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.2127014482136536
WEILL-MARCHESANI SYNDROME 2; WMS2	0.006024100000000001	0.2127014482136536
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.2127014482136536
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.2127014482136536
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.2127014482136536
COGAN SYNDROME	0.006024100000000001	0.2127014482136536
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.006024100000000001	0.2127014482136536
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.006024100000000001	0.2127014482136536
GLYCEROL KINASE DEFICIENCY; GKD	0.005981943	0.21121295118466282
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005981943	0.21121295118466282
COACH SYNDROME	0.005963603	0.21056539477619707
2P21 MICRODELETION SYNDROME	0.005963603	0.21056539477619707
VICI SYNDROME; VICIS	0.005963603	0.21056539477619707
KLEEFSTRA SYNDROME 2; KLEFS2	0.005963603	0.21056539477619707
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00581395	0.20528138391490364
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00581395	0.20528138391490364
GERMAN SYNDROME	0.00581395	0.20528138391490364
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.20528138391490364
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00581395	0.20528138391490364
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00581395	0.20528138391490364
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00581395	0.20528138391490364
EMERY-NELSON SYNDROME	0.00581395	0.20528138391490364
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00581395	0.20528138391490364
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00581395	0.20528138391490364
BETHLEM MYOPATHY 1	0.00581395	0.20528138391490364
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00581395	0.20528138391490364
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00581395	0.20528138391490364
AMISH NEMALINE MYOPATHY	0.00581395	0.20528138391490364
NEMALINE MYOPATHY 3; NEM3	0.00581395	0.20528138391490364
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00581395	0.20528138391490364
BETHLEM MYOPATHY	0.00581395	0.20528138391490364
RADICULONEUROPATHY, FATAL NEONATAL	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00581395	0.20528138391490364
TYPICAL NEMALINE MYOPATHY	0.00581395	0.20528138391490364
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00581395	0.20528138391490364
FG SYNDROME 2; FGS2	0.00581395	0.20528138391490364
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00581395	0.20528138391490364
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00581395	0.20528138391490364
MYOPATHY AND DIABETES MELLITUS	0.00581395	0.20528138391490364
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00581395	0.20528138391490364
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00581395	0.20528138391490364
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00581395	0.20528138391490364
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00581395	0.20528138391490364
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00581395	0.20528138391490364
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00581395	0.20528138391490364
ARGININEMIA	0.005759873	0.20337201052882942
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.005759873	0.20337201052882942
CENTRAL BILATERAL MACROGYRIA	0.005759873	0.20337201052882942
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005759873	0.20337201052882942
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005759873	0.20337201052882942
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.005759873	0.20337201052882942
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.005759873	0.20337201052882942
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005759873	0.20337201052882942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005759873	0.20337201052882942
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.005759873	0.20337201052882942
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00563688	0.1990293221238989
MOEBIUS SYNDROME	0.00563688	0.1990293221238989
PETERS PLUS SYNDROME	0.005604054	0.1978702879546352
FILIPPI SYNDROME; FLPIS	0.005599919	0.1977242876411671
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.005599919	0.1977242876411671
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00554358	0.1957350466108208
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00554358	0.1957350466108208
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005496862999999999	0.19408554319019408
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.19400246247977318
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.19400246247977318
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.19400246247977318
RAMOS-ARROYO SYNDROME	0.00549451	0.19400246247977318
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00549451	0.19400246247977318
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.19400246247977318
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.19400246247977318
DERMOCHONDROCORNEAL DYSTROPHY	0.00549451	0.19400246247977318
STARGARDT DISEASE 3; STGD3	0.00549451	0.19400246247977318
PRIMARY HYPEROXALURIA	0.00549451	0.19400246247977318
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.19400246247977318
NANOPHTHALMOS 4; NNO4	0.00549451	0.19400246247977318
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.19400246247977318
INTERMEDIATE UVEITIS	0.00549451	0.19400246247977318
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.19400246247977318
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.19400246247977318
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.19400246247977318
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.19400246247977318
KERATOCONUS 9; KTCN9	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.19400246247977318
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.19400246247977318
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.19400246247977318
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.19400246247977318
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.19400246247977318
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.19400246247977318
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.19400246247977318
MADRAS MOTOR NEURON DISEASE	0.00549451	0.19400246247977318
IRVAN SYNDROME	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.19400246247977318
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.19400246247977318
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.19400246247977318
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.19400246247977318
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.19400246247977318
FRIEDREICH ATAXIA	0.00549451	0.19400246247977318
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00549451	0.19400246247977318
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.19400246247977318
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.19400246247977318
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.19400246247977318
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.19400246247977318
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005478523	0.19343798678172838
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.005478523	0.19343798678172838
RFT1-CDG	0.005478523	0.19343798678172838
SMITH-LEMLI-OPITZ SYNDROME	0.005453233	0.19254503685969468
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005453233	0.19254503685969468
EMANUEL SYNDROME	0.005453233	0.19254503685969468
WOLF-HIRSCHHORN SYNDROME	0.005453233	0.19254503685969468
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005453233	0.19254503685969468
BOHRING-OPITZ SYNDROME	0.005453233	0.19254503685969468
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005453233	0.19254503685969468
COFFIN-SIRIS SYNDROME	0.005453233	0.19254503685969468
COHEN SYNDROME	0.005453233	0.19254503685969468
19P13.12 MICRODELETION SYNDROME	0.005453233	0.19254503685969468
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.005453233	0.19254503685969468
22Q11.2 DELETION SYNDROME	0.005453233	0.19254503685969468
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.005440524	0.19209630215984783
JOUBERT SYNDROME 14	0.005440524	0.19209630215984783
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.005440524	0.19209630215984783
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005440524	0.19209630215984783
NEPHRONOPHTHISIS 11; NPHP11	0.005440524	0.19209630215984783
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.005440524	0.19209630215984783
DUPLICATION/INVERSION 15Q11	0.005436389	0.19195030184637968
ACROCALLOSAL SYNDROME; ACLS	0.005436389	0.19195030184637968
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005422184	0.1914487457513821
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005422184	0.1914487457513821
THYROID HEMIAGENESIS	0.005422184	0.1914487457513821
GALACTOSE EPIMERASE DEFICIENCY	0.005422184	0.1914487457513821
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.005422184	0.1914487457513821
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.005422184	0.1914487457513821
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.005422184	0.1914487457513821
FAMILIAL DYSAUTONOMIA	0.0054180489999999994	0.19130274543791395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0054180489999999994	0.19130274543791395
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0054180489999999994	0.19130274543791395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0054180489999999994	0.19130274543791395
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0054180489999999994	0.19130274543791395
14Q12 MICRODELETION SYNDROME	0.0054180489999999994	0.19130274543791395
LATHOSTEROLOSIS	0.0054180489999999994	0.19130274543791395
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.18425536150401442
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.005218454	0.18425536150401442
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005218454	0.18425536150401442
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.18410936119054627
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.18410936119054627
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.18410936119054627
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.005214319	0.18410936119054627
HUNTINGTON DISEASE-LIKE 1	0.005214319	0.18410936119054627
NEUROCUTANEOUS MELANOCYTOSIS	0.005214319	0.18410936119054627
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005214319	0.18410936119054627
PARTINGTON SYNDROME	0.005214319	0.18410936119054627
RETT SYNDROME	0.005214319	0.18410936119054627
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005214319	0.18410936119054627
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.18410936119054627
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.18410936119054627
DERMOTRICHIC SYNDROME	0.005214319	0.18410936119054627
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.005214319	0.18410936119054627
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.18410936119054627
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.18410936119054627
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.18410936119054627
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.18410936119054627
AUTISM	0.005214319	0.18410936119054627
EPILEPSY, READING	0.005214319	0.18410936119054627
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.005214319	0.18410936119054627
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.18410936119054627
ATYPICAL RETT SYNDROME	0.005214319	0.18410936119054627
ZLOTOGORA-OGUR SYNDROME	0.005214319	0.18410936119054627
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.18410936119054627
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.005214319	0.18410936119054627
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.18410936119054627
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.18410936119054627
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.18410936119054627
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.18410936119054627
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.005214319	0.18410936119054627
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.18410936119054627
SUPRABULBAR PARESIS, CONGENITAL	0.005214319	0.18410936119054627
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.18410936119054627
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.18410936119054627
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.18410936119054627
OSTEOGENESIS IMPERFECTA	0.0050585	0.17860763861635207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0050585	0.17860763861635207
TREACHER-COLLINS SYNDROME	0.004955444	0.17496889416537909
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004955444	0.17496889416537909
HYPERTRYPTOPHANEMIA; HYPTRP	0.004955444	0.17496889416537909
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004951309	0.17482289385191097
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.004951309	0.17482289385191097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004951309	0.17482289385191097
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0049371039999999995	0.17432133775691336
TRIPLE A SYNDROME	0.004932969	0.1741753374434452
KALLMANN SYNDROME	0.004932969	0.1741753374434452
INFANTILE NEUROAXONAL DYSTROPHY	0.004932969	0.1741753374434452
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0049118140000000005	0.17342838783487968
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.004911814	0.17342838783487963
TRISOMY 17P	0.004911814	0.17342838783487963
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004907679	0.1732823875214115
MARDEN-WALKER SYNDROME	0.004907679	0.1732823875214115
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00489497	0.17283365282156468
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00487663	0.17218609641309895
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00487663	0.17218609641309895
ESOPHAGEAL ATRESIA	0.00487663	0.17218609641309895
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00487663	0.17218609641309895
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00487663	0.17218609641309895
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00487663	0.17218609641309895
GLYCOGEN STORAGE DISEASE IXC	0.00487663	0.17218609641309895
HYPOTONIA-CYSTINURIA SYNDROME	0.00487663	0.17218609641309895
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004736613000000001	0.16724231747939416
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004736613000000001	0.16724231747939416
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004736613000000001	0.16724231747939416
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004736613000000001	0.16724231747939416
RING CHROMOSOME 22 SYNDROME	0.004736613000000001	0.16724231747939416
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.004736613000000001	0.16724231747939416
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004736613000000001	0.16724231747939416
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004736613000000001	0.16724231747939416
CLASSIC PHENYLKETONURIA	0.004736613000000001	0.16724231747939416
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004736613000000001	0.16724231747939416
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004736613000000001	0.16724231747939416
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004736613000000001	0.16724231747939416
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004736613000000001	0.16724231747939416
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.16499271216573125
HUNTINGTON DISEASE	0.0046729	0.16499271216573125
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.16499271216573125
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.0046729	0.16499271216573125
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.0046729	0.16499271216573125
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.16499271216573125
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.16499271216573125
ISAAC SYNDROME	0.0046729	0.16499271216573125
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.16499271216573125
ARGININOSUCCINIC ACIDURIA	0.0046729	0.16499271216573125
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.0046729	0.16499271216573125
SCHIZOPHRENIA	0.0046729	0.16499271216573125
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.16499271216573125
SACCHAROPINURIA	0.0046729	0.16499271216573125
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0046729	0.16499271216573125
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.16499271216573125
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0046729	0.16499271216573125
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.16499271216573125
OCULOCUTANEOUS ALBINISM TYPE 4	0.00440989	0.15570624482709594
X-LINKED RETINAL DYSPLASIA	0.00440989	0.15570624482709594
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00440989	0.15570624482709594
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00440989	0.15570624482709594
APERT SYNDROME	0.00440989	0.15570624482709594
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00440989	0.15570624482709594
RENAL COLOBOMA SYNDROME	0.00440989	0.15570624482709594
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00440989	0.15570624482709594
BUSCHKE-OLLENDORFF SYNDROME	0.00440989	0.15570624482709594
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00440989	0.15570624482709594
SPASTIC PARAPLEGIA 16, X-LINKED	0.00440989	0.15570624482709594
ACRO-RENAL-OCULAR SYNDROME	0.00440989	0.15570624482709594
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00440989	0.15570624482709594
OCULOCUTANEOUS ALBINISM TYPE 2	0.00440989	0.15570624482709594
HALLERMANN-STREIFF SYNDROME	0.00440989	0.15570624482709594
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00439155	0.15505868841863021
MARFAN SYNDROME	0.00439155	0.15505868841863021
FETAL METHYLMERCURY SYNDROME	0.00439155	0.15505868841863021
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.15505868841863021
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.15505868841863021
ABETALIPOPROTEINEMIA	0.00439155	0.15505868841863021
GOLDENHAR SYNDROME	0.00439155	0.15505868841863021
JOHANSON-BLIZZARD SYNDROME; JBS	0.00436626	0.1541657384965965
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.15011490948492542
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.15011490948492542
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.15011490948492542
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.15011490948492542
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.15011490948492542
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.15011490948492542
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.15011490948492542
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004251533	0.15011490948492542
COFFIN-SIRIS SYNDROME 2; CSS2	0.004251533	0.15011490948492542
JABERI-ELAHI SYNDROME; JABELS	0.004251533	0.15011490948492542
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004251533	0.15011490948492542
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004251533	0.15011490948492542
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.15011490948492542
BOHRING-OPITZ SYNDROME	0.004226242999999999	0.14922195956289167
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.004226242999999999	0.14922195956289167
MATERNAL PHENYLKETONURIA	0.004226242999999999	0.14922195956289167
15Q24 MICRODELETION SYNDROME	0.004226242999999999	0.14922195956289167
DISTAL MONOSOMY 15Q	0.004226242999999999	0.14922195956289167
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.004226242999999999	0.14922195956289167
8P23.1 MICRODELETION SYNDROME	0.004226242999999999	0.14922195956289167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.004207903000000001	0.148574403154426
LATHOSTEROLOSIS	0.004207903000000001	0.148574403154426
FILIPPI SYNDROME	0.004207903000000001	0.148574403154426
WOLMAN DISEASE	0.004195194	0.14812566845457914
LIG4 SYNDROME	0.004195194	0.14812566845457914
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	0.14812566845457914
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.004195194	0.14812566845457914
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004195194	0.14812566845457914
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.004195194	0.14812566845457914
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.004195194	0.14812566845457914
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004195194	0.14812566845457914
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	0.14812566845457914
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.004195194	0.14812566845457914
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004195194	0.14812566845457914
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.004195194	0.14812566845457914
JOUBERT SYNDROME 10	0.004195194	0.14812566845457914
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004195194	0.14812566845457914
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.004195194	0.14812566845457914
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	0.14812566845457914
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	0.14812566845457914
MONOSOMY 13Q34	0.004195194	0.14812566845457914
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004195194	0.14812566845457914
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0041910590000000005	0.14797966814111102
ZIMMERMANN-LABAND SYNDROME	0.0041910590000000005	0.14797966814111102
HEREDITARY FRUCTOSE INTOLERANCE	0.0041910590000000005	0.14797966814111102
THREONINEMIA	0.0041910590000000005	0.14797966814111102
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0041910590000000005	0.14797966814111102
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0041910590000000005	0.14797966814111102
20Q13.33 MICRODELETION SYNDROME	0.0041910590000000005	0.14797966814111102
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0041910590000000005	0.14797966814111102
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.14797966814111102
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0041910590000000005	0.14797966814111102
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.1309982604601104
CRANIOTELENCEPHALIC DYSPLASIA	0.0037101139999999996	0.1309982604601104
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.1309982604601104
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0037101139999999996	0.1309982604601104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.1309982604601104
N SYNDROME	0.0037101139999999996	0.1309982604601104
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.1309982604601104
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003705979	0.13085226014664225
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13085226014664225
PAPILLOMA OF CHOROID PLEXUS	0.003705979	0.13085226014664225
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003705979	0.13085226014664225
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13085226014664225
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13085226014664225
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0036848239999999997	0.13010531053807667
FLOATING-HARBOR SYNDROME	0.0036848239999999997	0.13010531053807667
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0036848239999999997	0.13010531053807667
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0036848239999999997	0.13010531053807667
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0036848239999999997	0.13010531053807667
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0036848239999999997	0.13010531053807667
DISTAL TRISOMY 6P	0.0036848239999999997	0.13010531053807667
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0036848239999999997	0.13010531053807667
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0036848239999999997	0.13010531053807667
FETAL TRIMETHADIONE SYNDROME	0.0036848239999999997	0.13010531053807667
FETAL HYDANTOIN SYNDROME	0.0036848239999999997	0.13010531053807667
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036848239999999997	0.13010531053807667
SECKEL SYNDROME 1; SCKL1	0.003680689	0.12995931022460855
BRANCHIOOCULOFACIAL SYNDROME	0.003680689	0.12995931022460855
DUBOWITZ SYNDROME	0.003680689	0.12995931022460855
MARDEN-WALKER SYNDROME	0.0036664840000000002	0.12945775412961097
TRISOMY 18	0.0036664840000000002	0.12945775412961097
RITSCHER-SCHINZEL SYNDROME 1	0.0036664840000000002	0.12945775412961097
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.0036664840000000002	0.12945775412961097
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0036664840000000002	0.12945775412961097
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0036664840000000002	0.12945775412961097
COLE-CARPENTER SYNDROME	0.0036664840000000002	0.12945775412961097
XQ27.3Q28 DUPLICATION SYNDROME	0.0036664840000000002	0.12945775412961097
12Q14 MICRODELETION SYNDROME	0.0036664840000000002	0.12945775412961097
20Q11.2 MICRODELETION SYNDROME	0.0036664840000000002	0.12945775412961097
CUTIS LAXA	0.0036664840000000002	0.12945775412961097
DISTAL MONOSOMY 3P	0.003662349	0.1293117538161428
RING CHROMOSOME 10 SYNDROME	0.003662349	0.1293117538161428
WIEDEMANN-STEINER SYNDROME	0.003662349	0.1293117538161428
THANATOPHORIC DYSPLASIA	0.003662349	0.1293117538161428
ACROCARDIOFACIAL SYNDROME	0.003662349	0.1293117538161428
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.003662349	0.1293117538161428
DISTAL TRISOMY 15Q	0.003662349	0.1293117538161428
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	0.128863019116296
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	0.128863019116296
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	0.128863019116296
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.128863019116296
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00364964	0.128863019116296
3MC SYNDROME 3	0.00364964	0.128863019116296
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	0.128863019116296
HARDIKAR SYNDROME	0.00364964	0.128863019116296
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	0.128863019116296
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.128863019116296
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	0.128863019116296
MAJEED SYNDROME	0.00364964	0.128863019116296
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.128863019116296
CRYPTOSPORIDIOSIS	0.00364964	0.128863019116296
AXENFELD-RIEGER SYNDROME	0.00364964	0.128863019116296
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.128863019116296
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.128863019116296
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	0.128863019116296
CERNUNNOS-XLF DEFICIENCY	0.00364964	0.128863019116296
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.128863019116296
FRANK-TER HAAR SYNDROME; FTHS	0.00364964	0.128863019116296
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.128863019116296
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.128863019116296
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.128863019116296
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.128863019116296
AROMATASE DEFICIENCY	0.00364964	0.128863019116296
CUSHING SYNDROME	0.00364964	0.128863019116296
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.128863019116296
JUVENILE POLYPOSIS SYNDROME	0.00364964	0.128863019116296
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	0.128863019116296
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	0.128863019116296
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.128863019116296
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.128863019116296
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.128863019116296
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.128863019116296
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.128863019116296
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.128863019116296
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.128863019116296
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.128863019116296
T-SUBSTANCE ANOMALY	0.00364964	0.128863019116296
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.128863019116296
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.128863019116296
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.128863019116296
NEPHRONOPHTHISIS 1	0.00364964	0.128863019116296
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	0.128863019116296
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.128863019116296
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00364964	0.128863019116296
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00364964	0.128863019116296
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.128863019116296
CINCA SYNDROME; CINCA	0.00364964	0.128863019116296
BARTH SYNDROME; BTHS	0.00364964	0.128863019116296
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.128863019116296
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.128863019116296
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.128863019116296
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00364964	0.128863019116296
SERKAL SYNDROME	0.00364964	0.128863019116296
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	0.128863019116296
LYSINE MALABSORPTION SYNDROME	0.00364964	0.128863019116296
FAMILIAL HYPOALDOSTERONISM	0.00364964	0.128863019116296
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.128863019116296
RING CHROMOSOME 13 SYNDROME	0.00364964	0.128863019116296
NATHALIE SYNDROME	0.00364964	0.128863019116296
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.128863019116296
HEREDITARY SPHEROCYTOSIS	0.00364964	0.128863019116296
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.128863019116296
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.128863019116296
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	0.128863019116296
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	0.128863019116296
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.128863019116296
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.128863019116296
CHYLOMICRON RETENTION DISEASE	0.00364964	0.128863019116296
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.128863019116296
NEPHRONOPHTHISIS 4	0.00364964	0.128863019116296
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	0.128863019116296
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	0.128863019116296
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.128863019116296
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00364964	0.128863019116296
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.128863019116296
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.128863019116296
CITRULLINE TRANSPORT DEFECT	0.00364964	0.128863019116296
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.128863019116296
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.128863019116296
ALPHA-HEAVY CHAIN DISEASE	0.00364964	0.128863019116296
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.128863019116296
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0035592930000000003	0.12567300936516984
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0035592930000000003	0.12567300936516984
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0035592930000000003	0.12567300936516984
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0035592930000000003	0.12567300936516984
MONOSOMY 9Q22.3	0.0035592930000000003	0.12567300936516984
KABUKI SYNDROME 1	0.0035592930000000003	0.12567300936516984
2Q31.1 MICRODELETION SYNDROME	0.0035592930000000003	0.12567300936516984
MONOSOMY 9P	0.0035592930000000003	0.12567300936516984
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0035592930000000003	0.12567300936516984
15Q13.3 MICRODELETION SYNDROME	0.0035592930000000003	0.12567300936516984
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0035592930000000003	0.12567300936516984
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0035592930000000003	0.12567300936516984
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0035592930000000003	0.12567300936516984
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.0035592930000000003	0.12567300936516984
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0035592930000000003	0.12567300936516984
C SYNDROME	0.0035592930000000003	0.12567300936516984
49,XXXXY SYNDROME	0.0035592930000000003	0.12567300936516984
WEAVER SYNDROME	0.0035592930000000003	0.12567300936516984
1Q21.1 MICRODUPLICATION SYNDROME	0.0035592930000000003	0.12567300936516984
48,XXXY SYNDROME	0.0035592930000000003	0.12567300936516984
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0035592930000000003	0.12567300936516984
CHROMOSOME 10Q26 DELETION SYNDROME	0.0035592930000000003	0.12567300936516984
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0035592930000000003	0.12567300936516984
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11173561112182723
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11173561112182723
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.11173561112182723
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.11173561112182723
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11173561112182723
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11173561112182723
JALILI SYNDROME	0.00316456	0.11173561112182723
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11173561112182723
PROLIDASE DEFICIENCY	0.00316456	0.11173561112182723
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00316456	0.11173561112182723
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11173561112182723
FISH-EYE DISEASE	0.00316456	0.11173561112182723
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11173561112182723
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11173561112182723
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11173561112182723
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11173561112182723
CONE ROD DYSTROPHY	0.00316456	0.11173561112182723
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11173561112182723
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11173561112182723
WAGR SYNDROME	0.00316456	0.11173561112182723
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11173561112182723
BRADYOPSIA	0.00316456	0.11173561112182723
GAPO SYNDROME	0.00316456	0.11173561112182723
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11173561112182723
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11173561112182723
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11173561112182723
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11173561112182723
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11173561112182723
GMEZ-LPEZ-HERNNDEZ SYNDROME	0.00316456	0.11173561112182723
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11173561112182723
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.11173561112182723
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11173561112182723
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11173561112182723
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11173561112182723
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11173561112182723
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11173561112182723
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.11173561112182723
BETA-THALASSEMIA MAJOR	0.00316456	0.11173561112182723
CYSTINOSIS	0.00316456	0.11173561112182723
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11173561112182723
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11173561112182723
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11173561112182723
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11173561112182723
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11173561112182723
GILLESPIE SYNDROME; GLSP	0.00316456	0.11173561112182723
TANGIER DISEASE; TGD	0.00316456	0.11173561112182723
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11173561112182723
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11173561112182723
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.11173561112182723
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.11173561112182723
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.11173561112182723
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11173561112182723
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11173561112182723
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11173561112182723
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.11173561112182723
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11173561112182723
MMEP SYNDROME	0.00316456	0.11173561112182723
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11173561112182723
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11173561112182723
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11173561112182723
ERDHEIM-CHESTER DISEASE	0.00316456	0.11173561112182723
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11173561112182723
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11173561112182723
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11173561112182723
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11173561112182723
BLUE CONE MONOCHROMATISM	0.00316456	0.11173561112182723
MUCOLIPIDOSIS TYPE III	0.00316456	0.11173561112182723
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11173561112182723
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11173561112182723
ASCHER SYNDROME	0.00316456	0.11173561112182723
N SYNDROME	0.00316456	0.11173561112182723
MALT LYMPHOMA	0.00316456	0.11173561112182723
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.11173561112182723
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11173561112182723
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11173561112182723
ALBINISM, OCULAR, TYPE I	0.00316456	0.11173561112182723
MANGANESE POISONING	0.00316456	0.11173561112182723
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00313927	0.11084266119979352
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00313927	0.11084266119979352
MOSAIC MONOSOMY X	0.00313927	0.11084266119979352
ELLIS VAN CREVELD SYNDROME	0.00313927	0.11084266119979352
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00313927	0.11084266119979352
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00313927	0.11084266119979352
PROGEROID SYNDROME, PETTY TYPE	0.00313927	0.11084266119979352
BRANCHIO-OCULO-FACIAL SYNDROME	0.00313927	0.11084266119979352
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00313927	0.11084266119979352
MONOSOMY X	0.00313927	0.11084266119979352
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00313927	0.11084266119979352
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00313927	0.11084266119979352
LAMBOTTE SYNDROME	0.00313927	0.11084266119979352
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00313927	0.11084266119979352
ALAGILLE SYNDROME	0.00313927	0.11084266119979352
TURNER SYNDROME	0.00313927	0.11084266119979352
MEIER-GORLIN SYNDROME 1; MGORS1	0.00313927	0.11084266119979352
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00312093	0.11019510479132781
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00312093	0.11019510479132781
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00312093	0.11019510479132781
THAKKER-DONNAI SYNDROME	0.00312093	0.11019510479132781
MONOSOMY 13Q14	0.00312093	0.11019510479132781
DIASTROPHIC DWARFISM	0.00312093	0.11019510479132781
CAT-EYE SYNDROME	0.00312093	0.11019510479132781
LAMBERT SYNDROME	0.00312093	0.11019510479132781
IMAGE SYNDROME	0.00312093	0.11019510479132781
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00312093	0.11019510479132781
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00312093	0.11019510479132781
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00312093	0.11019510479132781
JOHANSON-BLIZZARD SYNDROME	0.00312093	0.11019510479132781
PEARSON SYNDROME	0.00312093	0.11019510479132781
MATTHEW-WOOD SYNDROME	0.00312093	0.11019510479132781
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00312093	0.11019510479132781
NEUROFACIODIGITORENAL SYNDROME	0.00312093	0.11019510479132781
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0030178740000000003	0.10655636034035483
TOLUENE EMBRYOPATHY	0.0030178740000000003	0.10655636034035483
HADZISELIMOVIC SYNDROME	0.0030178740000000003	0.10655636034035483
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.0030178740000000003	0.10655636034035483
CRANIOSYNOSTOSIS 6; CRS6	0.0030178740000000003	0.10655636034035483
GERMAN SYNDROME	0.0030178740000000003	0.10655636034035483
MARINESCO-SJGREN SYNDROME	0.0030178740000000003	0.10655636034035483
2Q32Q33 MICRODELETION SYNDROME	0.0030178740000000003	0.10655636034035483
ARTERIAL TORTUOSITY SYNDROME	0.0030178740000000003	0.10655636034035483
CODAS SYNDROME	0.0030178740000000003	0.10655636034035483
MOWAT-WILSON SYNDROME	0.003013739	0.10641036002688668
5Q14.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688668
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003013739	0.10641036002688668
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.003013739	0.10641036002688668
CHROMOSOME 18Q DELETION SYNDROME	0.003013739	0.10641036002688668
PALLISTER-KILLIAN SYNDROME	0.003013739	0.10641036002688668
FRAGILE X SYNDROME	0.003013739	0.10641036002688668
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688668
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003013739	0.10641036002688668
NOONAN SYNDROME 7; NS7	0.003013739	0.10641036002688668
LEIGH SYNDROME	0.003013739	0.10641036002688668
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002980913	0.10525132585762301
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002980913	0.10525132585762301
STT3B-CDG	0.002980913	0.10525132585762301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002980913	0.10525132585762301
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.002980913	0.10525132585762301
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002980913	0.10525132585762301
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002980913	0.10525132585762301
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002980913	0.10525132585762301
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.002980913	0.10525132585762301
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002980913	0.10525132585762301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002980913	0.10525132585762301
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002980913	0.10525132585762301
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.002980913	0.10525132585762301
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002980913	0.10525132585762301
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002980913	0.10525132585762301
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002980913	0.10525132585762301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002980913	0.10525132585762301
CATEL-MANZKE SYNDROME; CATMANS	0.002980913	0.10525132585762301
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002980913	0.10525132585762301
AL KAISSI SYNDROME; ALKAS	0.002980913	0.10525132585762301
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002980913	0.10525132585762301
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002980913	0.10525132585762301
RUVALCABA SYNDROME	0.002980913	0.10525132585762301
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002980913	0.10525132585762301
COFFIN-SIRIS SYNDROME 5	0.002980913	0.10525132585762301
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002980913	0.10525132585762301
PETERS-PLUS SYNDROME; PTRPLS	0.002980913	0.10525132585762301
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002980913	0.10525132585762301
MACDERMOT-WINTER SYNDROME	0.002980913	0.10525132585762301
PALLISTER-HALL SYNDROME	0.002980913	0.10525132585762301
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207167
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00247232	0.08729371100207167
STEINERT MYOTONIC DYSTROPHY	0.00247232	0.08729371100207167
TRISOMY 20P	0.00247232	0.08729371100207167
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00247232	0.08729371100207167
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00247232	0.08729371100207167
TRISOMY 4P	0.00247232	0.08729371100207167
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00247232	0.08729371100207167
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00247232	0.08729371100207167
NON-DISTAL MONOSOMY 10Q	0.00247232	0.08729371100207167
8Q21.11 MICRODELETION SYNDROME	0.00247232	0.08729371100207167
NOONAN SYNDROME	0.00247232	0.08729371100207167
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00247232	0.08729371100207167
TETRASOMY 12P	0.00247232	0.08729371100207167
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00247232	0.08729371100207167
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207167
6P22 MICRODELETION SYNDROME	0.00247232	0.08729371100207167
COOPER-JABS SYNDROME	0.00247232	0.08729371100207167
REVESZ SYNDROME	0.002439494	0.08613467683280798
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002439494	0.08613467683280798
MOSAIC TRISOMY 9	0.002439494	0.08613467683280798
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.002439494	0.08613467683280798
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002439494	0.08613467683280798
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002439494	0.08613467683280798
DYSKERATOSIS CONGENITA	0.002439494	0.08613467683280798
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.002439494	0.08613467683280798
DIAPHANOSPONDYLODYSOSTOSIS	0.002439494	0.08613467683280798
BRESEK SYNDROME	0.002439494	0.08613467683280798
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.002439494	0.08613467683280798
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002439494	0.08613467683280798
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.002439494	0.08613467683280798
HOYERAAL-HREIDARSSON SYNDROME	0.002439494	0.08613467683280798
SYNDROMIC DIARRHEA	0.002439494	0.08613467683280798
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.002439494	0.08613467683280798
SAUL-WILSON SYNDROME; SWILS	0.002439494	0.08613467683280798
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002439494	0.08613467683280798
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002439494	0.08613467683280798
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002439494	0.08613467683280798
%300712 CRANIOFACIOSKELETAL SYNDROME	0.002439494	0.08613467683280798
RABSON-MENDENHALL SYNDROME	0.002439494	0.08613467683280798
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002439494	0.08613467683280798
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.002439494	0.08613467683280798
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.002439494	0.08613467683280798
SECKEL SYNDROME 9; SCKL9	0.002439494	0.08613467683280798
OCULO-PALATO-CEREBRAL SYNDROME	0.002439494	0.08613467683280798
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.002439494	0.08613467683280798
CONGENITAL VARICELLA SYNDROME	0.002439494	0.08613467683280798
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002439494	0.08613467683280798
DE BARSY SYNDROME	0.002439494	0.08613467683280798
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.002439494	0.08613467683280798
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002439494	0.08613467683280798
SILVER-RUSSELL SYNDROME; SRS	0.002439494	0.08613467683280798
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.002439494	0.08613467683280798
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002439494	0.08613467683280798
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002439494	0.08613467683280798
WARSAW BREAKAGE SYNDROME; WABS	0.002439494	0.08613467683280798
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002439494	0.08613467683280798
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.002439494	0.08613467683280798
TARP SYNDROME; TARPS	0.002439494	0.08613467683280798
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.002439494	0.08613467683280798
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002439494	0.08613467683280798
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.002439494	0.08613467683280798
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002439494	0.08613467683280798
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002439494	0.08613467683280798
EAR-PATELLA-SHORT STATURE SYNDROME	0.002439494	0.08613467683280798
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002439494	0.08613467683280798
LOWRY-MACLEAN SYNDROME	0.002439494	0.08613467683280798
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.002439494	0.08613467683280798
RETINITIS PIGMENTOSA 59; RP59	0.002435359	0.08598867651933984
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002435359	0.08598867651933984
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002435359	0.08598867651933984
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002435359	0.08598867651933984
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002435359	0.08598867651933984
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002435359	0.08598867651933984
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.002435359	0.08598867651933984
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002435359	0.08598867651933984
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002435359	0.08598867651933984
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002435359	0.08598867651933984
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002435359	0.08598867651933984
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002435359	0.08598867651933984
KAPUR-TORIELLO SYNDROME	0.002435359	0.08598867651933984
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.002435359	0.08598867651933984
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.002435359	0.08598867651933984
HARROD SYNDROME	0.002435359	0.08598867651933984
3-HYDROXYISOBUTYRIC ACIDURIA	0.002435359	0.08598867651933984
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002435359	0.08598867651933984
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002435359	0.08598867651933984
MENKES DISEASE	0.002435359	0.08598867651933984
11Q22.2Q22.3 MICRODELETION SYNDROME	0.002332303	0.08234993206836687
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002332303	0.08234993206836687
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08234993206836687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.002332303	0.08234993206836687
PONTINE TEGMENTAL CAP DYSPLASIA	0.002332303	0.08234993206836687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08234993206836687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002332303	0.08234993206836687
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08234993206836687
RUBINSTEIN-TAYBI SYNDROME	0.002332303	0.08234993206836687
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08234993206836687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002332303	0.08234993206836687
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002332303	0.08234993206836687
CK SYNDROME	0.002332303	0.08234993206836687
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002332303	0.08234993206836687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08234993206836687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002332303	0.08234993206836687
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.002332303	0.08234993206836687
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002332303	0.08234993206836687
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08234993206836687
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.002332303	0.08234993206836687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002332303	0.08234993206836687
ADAMS-OLIVER SYNDROME 2; AOS2	0.002332303	0.08234993206836687
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002332303	0.08234993206836687
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002332303	0.08234993206836687
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002332303	0.08234993206836687
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.002332303	0.08234993206836687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002332303	0.08234993206836687
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.002332303	0.08234993206836687
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08234993206836687
MEHMO SYNDROME; MEHMO	0.002332303	0.08234993206836687
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002332303	0.08234993206836687
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.002332303	0.08234993206836687
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002332303	0.08234993206836687
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002332303	0.08234993206836687
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08234993206836687
SSR4-CDG	0.002332303	0.08234993206836687
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002332303	0.08234993206836687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08234993206836687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08234993206836687
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.002332303	0.08234993206836687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002332303	0.08234993206836687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.002332303	0.08234993206836687
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002332303	0.08234993206836687
19P13.13 MICRODELETION SYNDROME	0.002332303	0.08234993206836687
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08234993206836687
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.002332303	0.08234993206836687
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08234993206836687
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002332303	0.08234993206836687
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002332303	0.08234993206836687
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002332303	0.08234993206836687
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002332303	0.08234993206836687
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.002332303	0.08234993206836687
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002313963	0.08170237565990114
MAPLE SYRUP URINE DISEASE	0.002313963	0.08170237565990114
DPAGT1-CDG	0.002313963	0.08170237565990114
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.002313963	0.08170237565990114
GRISCELLI SYNDROME	0.002313963	0.08170237565990114
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002313963	0.08170237565990114
SIMPSON-GOLABI-BEHMEL SYNDROME	0.002313963	0.08170237565990114
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002313963	0.08170237565990114
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002313963	0.08170237565990114
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002313963	0.08170237565990114
KLEEFSTRA SYNDROME	0.002313963	0.08170237565990114
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.002313963	0.08170237565990114
15Q11Q13 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990114
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08170237565990114
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990114
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002313963	0.08170237565990114
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08170237565990114
CODAS SYNDROME	0.002313963	0.08170237565990114
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002313963	0.08170237565990114
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002313963	0.08170237565990114
FOLATE MALABSORPTION, HEREDITARY	0.002313963	0.08170237565990114
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002313963	0.08170237565990114
2Q37 MICRODELETION SYNDROME	0.002313963	0.08170237565990114
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08170237565990114
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.002313963	0.08170237565990114
FUCOSIDOSIS	0.002313963	0.08170237565990114
METHYLMALONIC ACIDURIA, CBLA TYPE	0.002313963	0.08170237565990114
MEVALONIC ACIDURIA	0.002313963	0.08170237565990114
PELIZAEUS-MERZBACHER DISEASE	0.002313963	0.08170237565990114
TRISOMY X	0.002313963	0.08170237565990114
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08170237565990114
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002313963	0.08170237565990114
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002313963	0.08170237565990114
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990114
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002313963	0.08170237565990114
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08170237565990114
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990114
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990114
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.002313963	0.08170237565990114
20P12.3 MICRODELETION SYNDROME	0.002313963	0.08170237565990114
FREE SIALIC ACID STORAGE DISEASE	0.002313963	0.08170237565990114
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002313963	0.08170237565990114
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.002313963	0.08170237565990114
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002313963	0.08170237565990114
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990114
KETOADIPICACIDURIA	0.002313963	0.08170237565990114
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002313963	0.08170237565990114
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990114
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002313963	0.08170237565990114
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08170237565990114
DISTAL MONOSOMY 19P13.3	0.002313963	0.08170237565990114
WALKER-WARBURG SYNDROME	0.002313963	0.08170237565990114
HOLOPROSENCEPHALY 2; HPE2	0.002313963	0.08170237565990114
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.002313963	0.08170237565990114
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002313963	0.08170237565990114
HOLOPROSENCEPHALY	0.002313963	0.08170237565990114
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00189394	0.06687202749452482
MECKEL SYNDROME, TYPE 4; MKS4	0.00189394	0.06687202749452482
PHOCOMELIA, SCHINZEL TYPE	0.00189394	0.06687202749452482
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00189394	0.06687202749452482
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00189394	0.06687202749452482
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00189394	0.06687202749452482
FETAL AKINESIA DEFORMATION SEQUENCE	0.00189394	0.06687202749452482
CEREBROCOSTOMANDIBULAR SYNDROME	0.00189394	0.06687202749452482
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00189394	0.06687202749452482
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.06687202749452482
ENG-STROM SYNDROME	0.00189394	0.06687202749452482
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00189394	0.06687202749452482
BLOOM SYNDROME	0.00189394	0.06687202749452482
MECKEL SYNDROME, TYPE 1; MKS1	0.00189394	0.06687202749452482
PHAVER SYNDROME	0.00189394	0.06687202749452482
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00189394	0.06687202749452482
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00189394	0.06687202749452482
ACROFACIAL DYSOSTOSIS, RODRGUEZ TYPE	0.00189394	0.06687202749452482
3M SYNDROME	0.00189394	0.06687202749452482
TETRALOGY OF FALLOT	0.00189394	0.06687202749452482
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00189394	0.06687202749452482
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00189394	0.06687202749452482
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00189394	0.06687202749452482
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.00189394	0.06687202749452482
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00189394	0.06687202749452482
TETRAPLOIDY	0.00189394	0.06687202749452482
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00189394	0.06687202749452482
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00189394	0.06687202749452482
MULIBREY NANISM	0.00189394	0.06687202749452482
MARTINEZ-FRIAS SYNDROME	0.00189394	0.06687202749452482
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00189394	0.06687202749452482
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00189394	0.06687202749452482
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00189394	0.06687202749452482
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00189394	0.06687202749452482
TRIPLOIDY	0.00189394	0.06687202749452482
TRANSALDOLASE DEFICIENCY	0.00189394	0.06687202749452482
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00189394	0.06687202749452482
VACTERL WITH HYDROCEPHALUS	0.00189394	0.06687202749452482
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00189394	0.06687202749452482
CRANE-HEISE SYNDROME	0.00189394	0.06687202749452482
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.00189394	0.06687202749452482
HYDROLETHALUS SYNDROME 1	0.00189394	0.06687202749452482
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00189394	0.06687202749452482
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00189394	0.06687202749452482
BALLER-GEROLD SYNDROME	0.00189394	0.06687202749452482
JUBERG-HAYWARD SYNDROME	0.00189394	0.06687202749452482
ACRORENAL-MANDIBULAR SYNDROME	0.00189394	0.06687202749452482
MEIER-GORLIN SYNDROME 8; MGORS8	0.00189394	0.06687202749452482
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00189394	0.06687202749452482
MECKEL SYNDROME 12; MKS12	0.00189394	0.06687202749452482
19Q13.11 MICRODELETION SYNDROME	0.00189394	0.06687202749452482
NEU-LAXOVA SYNDROME 2; NLS2	0.00189394	0.06687202749452482
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00189394	0.06687202749452482
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00189394	0.06687202749452482
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00189394	0.06687202749452482
MITCHELL-RILEY SYNDROME; MTCHRS	0.00189394	0.06687202749452482
IMMUNODEFICIENCY 55; IMD55	0.00189394	0.06687202749452482
NIJMEGEN BREAKAGE SYNDROME	0.00189394	0.06687202749452482
VERVERI-BRADY SYNDROME; VERBRAS	0.00189394	0.06687202749452482
HOLZGREVE SYNDROME	0.00189394	0.06687202749452482
BLOOM SYNDROME	0.00189394	0.06687202749452482
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00189394	0.06687202749452482
ACRO-RENAL-MANDIBULAR SYNDROME	0.00189394	0.06687202749452482
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00189394	0.06687202749452482
METHIMAZOLE EMBRYOFETOPATHY	0.00189394	0.06687202749452482
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00189394	0.06687202749452482
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00189394	0.06687202749452482
BARTSOCAS-PAPAS SYNDROME; BPS	0.00189394	0.06687202749452482
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.06687202749452482
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00189394	0.06687202749452482
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00189394	0.06687202749452482
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00189394	0.06687202749452482
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00189394	0.06687202749452482
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00189394	0.06687202749452482
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00189394	0.06687202749452482
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00189394	0.06687202749452482
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00189394	0.06687202749452482
LEPRECHAUNISM	0.00189394	0.06687202749452482
NEU-LAXOVA SYNDROME	0.00189394	0.06687202749452482
ATRESIA OF SMALL INTESTINE	0.00189394	0.06687202749452482
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00189394	0.06687202749452482
ROIFMAN SYNDROME	0.00189394	0.06687202749452482
HEMOCHROMATOSIS, NEONATAL	0.00189394	0.06687202749452482
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00189394	0.06687202749452482
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00189394	0.06687202749452482
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00189394	0.06687202749452482
AREDYLD SYNDROME	0.00189394	0.06687202749452482
FRAXE INTELLECTUAL DISABILITY	0.00189394	0.06687202749452482
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.06687202749452482
GENITOPALATOCARDIAC SYNDROME	0.00189394	0.06687202749452482
SECKEL SYNDROME 4	0.00189394	0.06687202749452482
MEIER-GORLIN SYNDROME 2; MGORS2	0.00189394	0.06687202749452482
APPARENT MINERALOCORTICOID EXCESS	0.00189394	0.06687202749452482
MEIER-GORLIN SYNDROME 3; MGORS3	0.00189394	0.06687202749452482
MODY	0.00189394	0.06687202749452482
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00189394	0.06687202749452482
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00189394	0.06687202749452482
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00189394	0.06687202749452482
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00189394	0.06687202749452482
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00189394	0.06687202749452482
HARTSFIELD SYNDROME	0.00189394	0.06687202749452482
BRADDOCK SYNDROME	0.00189394	0.06687202749452482
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00189394	0.06687202749452482
TRICHOHEPATOENTERIC SYNDROME 2	0.00189394	0.06687202749452482
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00189394	0.06687202749452482
STIMMLER SYNDROME	0.00189394	0.06687202749452482
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00189394	0.06687202749452482
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.06687202749452482
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00189394	0.06687202749452482
GRACILE SYNDROME	0.00189394	0.06687202749452482
RUSSELL-SILVER SYNDROME, X-LINKED	0.00189394	0.06687202749452482
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.06323328304355186
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.06323328304355186
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.06323328304355186
MIETENS SYNDROME	0.001790884	0.06323328304355186
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06323328304355186
CHAR SYNDROME	0.001790884	0.06323328304355186
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06323328304355186
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.06323328304355186
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.001790884	0.06323328304355186
LAMB-SHAFFER SYNDROME	0.001790884	0.06323328304355186
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.06323328304355186
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001790884	0.06323328304355186
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.06323328304355186
MEIER-GORLIN SYNDROME 7	0.001790884	0.06323328304355186
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.06323328304355186
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06323328304355186
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001790884	0.06323328304355186
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.06323328304355186
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001790884	0.06323328304355186
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.06323328304355186
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.001790884	0.06323328304355186
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.06323328304355186
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.06323328304355186
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.06323328304355186
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.06323328304355186
3MC SYNDROME 2	0.001790884	0.06323328304355186
ROTHMUND-THOMSON SYNDROME	0.001790884	0.06323328304355186
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.06323328304355186
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001790884	0.06323328304355186
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001790884	0.06323328304355186
MARINESCO-SJOGREN SYNDROME; MSS	0.001790884	0.06323328304355186
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.06323328304355186
FRONTOOCULAR SYNDROME	0.001790884	0.06323328304355186
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001790884	0.06323328304355186
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06323328304355186
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001790884	0.06323328304355186
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.001790884	0.06323328304355186
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.06323328304355186
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.06323328304355186
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001790884	0.06323328304355186
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06323328304355186
CHAR SYNDROME	0.001790884	0.06323328304355186
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06323328304355186
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	0.06323328304355186
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.001790884	0.06323328304355186
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.06323328304355186
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.06323328304355186
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06308728273008371
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001786749	0.06308728273008371
INCONTINENTIA PIGMENTI; IP	0.001786749	0.06308728273008371
CHIME SYNDROME	0.001786749	0.06308728273008371
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001786749	0.06308728273008371
ATAXIA-TELANGIECTASIA	0.001786749	0.06308728273008371
SMITH-KINGSMORE SYNDROME; SKS	0.001786749	0.06308728273008371
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06308728273008371
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.001786749	0.06308728273008371
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.06308728273008371
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.06308728273008371
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.001786749	0.06308728273008371
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06308728273008371
PROTEUS SYNDROME	0.001786749	0.06308728273008371
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001786749	0.06308728273008371
BRANCHIOSKELETOGENITAL SYNDROME	0.001786749	0.06308728273008371
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.001786749	0.06308728273008371
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.06308728273008371
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.06308728273008371
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06308728273008371
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06308728273008371
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001786749	0.06308728273008371
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.06308728273008371
CONGENITAL HYDROCEPHALUS	0.001786749	0.06308728273008371
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06308728273008371
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.06308728273008371
MENTAL RETARDATION, X-LINKED 21	0.001786749	0.06308728273008371
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001786749	0.06308728273008371
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.06308728273008371
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001772544	0.06258572663508613
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06258572663508613
LATERAL MENINGOCELE SYNDROME	0.001772544	0.06258572663508613
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508613
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06258572663508613
LARSEN-LIKE SYNDROME	0.001772544	0.06258572663508613
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06258572663508613
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001772544	0.06258572663508613
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06258572663508613
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001772544	0.06258572663508613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06258572663508613
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06258572663508613
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001772544	0.06258572663508613
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.001772544	0.06258572663508613
FRIED SYNDROME	0.001772544	0.06258572663508613
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06258572663508613
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.001772544	0.06258572663508613
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001772544	0.06258572663508613
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.001772544	0.06258572663508613
WAARDENBURG-SHAH SYNDROME	0.001772544	0.06258572663508613
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001772544	0.06258572663508613
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508613
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001772544	0.06258572663508613
3C SYNDROME	0.001772544	0.06258572663508613
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06258572663508613
ALG6-CDG	0.001772544	0.06258572663508613
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06258572663508613
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508613
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001772544	0.06258572663508613
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508613
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.001772544	0.06258572663508613
MEVALONIC ACIDURIA; MEVA	0.001772544	0.06258572663508613
NIEMANN-PICK DISEASE, TYPE A	0.001772544	0.06258572663508613
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001772544	0.06258572663508613
ATHYREOSIS	0.001772544	0.06258572663508613
TRANSKETOLASE DEFICIENCY	0.001772544	0.06258572663508613
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06258572663508613
MONOSOMY 18P	0.001772544	0.06258572663508613
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.001772544	0.06258572663508613
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001772544	0.06258572663508613
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06258572663508613
THYROID ECTOPIA	0.001772544	0.06258572663508613
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06258572663508613
FAMILIAL THYROID DYSHORMONOGENESIS	0.001772544	0.06258572663508613
DISTAL MONOSOMY 9P	0.001772544	0.06258572663508613
THYROID HYPOPLASIA	0.001772544	0.06258572663508613
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001772544	0.06258572663508613
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06258572663508613
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06258572663508613
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001772544	0.06258572663508613
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508613
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508613
14Q22Q23 MICRODELETION SYNDROME	0.001772544	0.06258572663508613
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06258572663508613
CHROMOSOME 9P DELETION SYNDROME	0.001772544	0.06258572663508613
OCCIPITAL HORN SYNDROME	0.001772544	0.06258572663508613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06258572663508613
HURLER SYNDROME	0.001772544	0.06258572663508613
ALPHA-MANNOSIDOSIS	0.001772544	0.06258572663508613
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06258572663508613
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06258572663508613
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06258572663508613
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06258572663508613
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06258572663508613
17Q21.31 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508613
JOUBERT SYNDROME 8	0.001772544	0.06258572663508613
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06243972632161798
HYPOPHOSPHATASIA	0.001768409	0.06243972632161798
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06243972632161798
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.001768409	0.06243972632161798
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06243972632161798
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06243972632161798
FETAL GAUCHER DISEASE	0.001768409	0.06243972632161798
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06243972632161798
CAMOS SYNDROME	0.001768409	0.06243972632161798
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161798
ISOLATED SPINA BIFIDA	0.001768409	0.06243972632161798
CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161798
SJGREN-LARSSON SYNDROME	0.001768409	0.06243972632161798
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06243972632161798
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161798
ALG9-CDG	0.001768409	0.06243972632161798
ACUTE ADRENAL INSUFFICIENCY	0.001768409	0.06243972632161798
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.001768409	0.06243972632161798
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06243972632161798
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001768409	0.06243972632161798
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06243972632161798
ONDINE SYNDROME	0.001768409	0.06243972632161798
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06243972632161798
2Q23.1 MICRODELETION SYNDROME	0.001768409	0.06243972632161798
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001768409	0.06243972632161798
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06243972632161798
POTOCKI-SHAFFER SYNDROME	0.001768409	0.06243972632161798
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06243972632161798
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06243972632161798
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161798
OHDO SYNDROME	0.001768409	0.06243972632161798
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.001768409	0.06243972632161798
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001768409	0.06243972632161798
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001768409	0.06243972632161798
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.001768409	0.06243972632161798
BETA-KETOTHIOLASE DEFICIENCY	0.001768409	0.06243972632161798
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.001768409	0.06243972632161798
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001768409	0.06243972632161798
ASPARTYLGLUCOSAMINURIA; AGU	0.001768409	0.06243972632161798
HYPERLYSINEMIA, TYPE I	0.001768409	0.06243972632161798
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.001768409	0.06243972632161798
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06243972632161798
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06243972632161798
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06243972632161798
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06243972632161798
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001768409	0.06243972632161798
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06243972632161798
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.001768409	0.06243972632161798
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001768409	0.06243972632161798
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06243972632161798
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06243972632161798
1P36 MICRODELETION SYNDROME	0.001768409	0.06243972632161798
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001768409	0.06243972632161798
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06243972632161798
COFFIN-LOWRY SYNDROME; CLS	0.001768409	0.06243972632161798
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001768409	0.06243972632161798
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06243972632161798
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.0439706337052687
ODONTOCHONDRODYSPLASIA	0.00124533	0.0439706337052687
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.0439706337052687
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.0439706337052687
ANTLEY-BIXLER SYNDROME	0.00124533	0.0439706337052687
SCARF SYNDROME	0.00124533	0.0439706337052687
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.0439706337052687
PETERS ANOMALY	0.00124533	0.0439706337052687
GLUTATHIONURIA	0.00124533	0.0439706337052687
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.0439706337052687
MELNICK-NEEDLES SYNDROME	0.00124533	0.0439706337052687
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.0439706337052687
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.0439706337052687
WOOLLY HAIR	0.00124533	0.0439706337052687
FANCONI ANEMIA	0.00124533	0.0439706337052687
AASE-SMITH SYNDROME	0.00124533	0.0439706337052687
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.0439706337052687
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.0439706337052687
SCARF SYNDROME	0.00124533	0.0439706337052687
MASA SYNDROME	0.00124533	0.0439706337052687
PELVISCAPULAR DYSPLASIA	0.00124533	0.0439706337052687
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.0439706337052687
IVIC SYNDROME	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.0439706337052687
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.0439706337052687
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00124533	0.0439706337052687
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.0439706337052687
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.0439706337052687
FEMORAL-FACIAL SYNDROME	0.00124533	0.0439706337052687
HYPERTELORISM, TEEBI TYPE	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.0439706337052687
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00124533	0.0439706337052687
CHANARIN-DORFMAN SYNDROME	0.00124533	0.0439706337052687
JACKSON-WEISS SYNDROME	0.00124533	0.0439706337052687
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.0439706337052687
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.0439706337052687
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.0439706337052687
SUMMITT SYNDROME	0.00124533	0.0439706337052687
OTOMANDIBULAR SYNDROME	0.00124533	0.0439706337052687
COATS DISEASE	0.00124533	0.0439706337052687
FREEMAN-SHELDON SYNDROME	0.00124533	0.0439706337052687
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00124533	0.0439706337052687
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.0439706337052687
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.0439706337052687
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.0439706337052687
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.0439706337052687
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.0439706337052687
FOCAL DERMAL HYPOPLASIA	0.00124533	0.0439706337052687
CEREBROFACIOTHORACIC DYSPLASIA	0.00124533	0.0439706337052687
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.0439706337052687
FETAL IODINE SYNDROME	0.00124533	0.0439706337052687
MCDONOUGH SYNDROME	0.00124533	0.0439706337052687
PROXIMAL SYMPHALANGISM	0.00124533	0.0439706337052687
GASTROCUTANEOUS SYNDROME	0.00124533	0.0439706337052687
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.0439706337052687
PETERS ANOMALY	0.00124533	0.0439706337052687
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.0439706337052687
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.0439706337052687
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.0439706337052687
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.0439706337052687
GORLIN SYNDROME	0.00124533	0.0439706337052687
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.0439706337052687
MOSAIC TRISOMY 8	0.00124533	0.0439706337052687
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.0439706337052687
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.0439706337052687
SECKEL SYNDROME 5; SCKL5	0.00124533	0.0439706337052687
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.0439706337052687
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.0439706337052687
FRONTORHINY	0.00124533	0.0439706337052687
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.0439706337052687
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.0439706337052687
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00124533	0.0439706337052687
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.0439706337052687
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.0439706337052687
ROBINOW-SORAUF SYNDROME	0.00124533	0.0439706337052687
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.0439706337052687
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.0439706337052687
IVIC SYNDROME	0.00124533	0.0439706337052687
HEMIFACIAL MICROSOMIA	0.00124533	0.0439706337052687
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.0439706337052687
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.0439706337052687
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.0439706337052687
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.0439706337052687
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.0439706337052687
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.0439706337052687
CROSSED POLYSYNDACTYLY	0.00124533	0.0439706337052687
MULTIMINICORE MYOPATHY	0.00124533	0.0439706337052687
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00124533	0.0439706337052687
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.0439706337052687
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0439706337052687
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.0439706337052687
COSTELLO SYNDROME	0.00124533	0.0439706337052687
MCDONOUGH SYNDROME	0.00124533	0.0439706337052687
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.0439706337052687
15Q26 OVERGROWTH SYNDROME	0.00124533	0.0439706337052687
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.0439706337052687
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.0439706337052687
ABDUCENS PALSY	0.00124533	0.0439706337052687
MEIER-GORLIN SYNDROME 6; MGORS6	0.00124533	0.0439706337052687
BASAL CELL NEVUS SYNDROME	0.00124533	0.0439706337052687
LERI PLEONOSTEOSIS	0.00124533	0.0439706337052687
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.0439706337052687
STIFF SKIN SYNDROME	0.00124533	0.0439706337052687
MLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.0439706337052687
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.0439706337052687
LAURENCE-MOON SYNDROME	0.00124533	0.0439706337052687
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.0439706337052687
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00124533	0.0439706337052687
NATIVE AMERICAN MYOPATHY	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.04332307729680297
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.04332307729680297
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04332307729680297
KENNEDY DISEASE	0.00122699	0.04332307729680297
PRADER-WILLI SYNDROME (TYPE 1)	0.00122699	0.04332307729680297
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00122699	0.04332307729680297
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.04332307729680297
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04332307729680297
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00122699	0.04332307729680297
3Q13 MICRODELETION SYNDROME	0.00122699	0.04332307729680297
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04332307729680297
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00122699	0.04332307729680297
B4GALT1-CDG	0.00122699	0.04332307729680297
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.04332307729680297
WARBURG MICRO SYNDROME 1	0.00122699	0.04332307729680297
KEARNS-SAYRE SYNDROME	0.00122699	0.04332307729680297
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04332307729680297
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.04332307729680297
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 13	0.00122699	0.04332307729680297
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.04332307729680297
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.04332307729680297
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04332307729680297
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00122699	0.04332307729680297
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.04332307729680297
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.04332307729680297
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.04332307729680297
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00122699	0.04332307729680297
POLYMYOSITIS	0.00122699	0.04332307729680297
NEMALINE MYOPATHY 4	0.00122699	0.04332307729680297
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.04332307729680297
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.04332307729680297
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.04332307729680297
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.04332307729680297
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.04332307729680297
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.04332307729680297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.04332307729680297
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00122699	0.04332307729680297
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.04332307729680297
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.04332307729680297
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.04332307729680297
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.04332307729680297
MACS SYNDROME	0.00122699	0.04332307729680297
CENTRAL CORE DISEASE	0.00122699	0.04332307729680297
CAREY-FINEMAN-ZITER SYNDROME	0.00122699	0.04332307729680297
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.04332307729680297
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00122699	0.04332307729680297
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.04332307729680297
ANTISYNTHETASE SYNDROME	0.00122699	0.04332307729680297
PIEBALDISM	0.00122699	0.04332307729680297
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.04332307729680297
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04332307729680297
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00122699	0.04332307729680297
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.04332307729680297
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.04332307729680297
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.04332307729680297
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.04332307729680297
DERMATOMYOSITIS	0.00122699	0.04332307729680297
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00122699	0.04332307729680297
INFANTILE SYSTEMIC HYALINOSIS	0.00122699	0.04332307729680297
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00122699	0.04332307729680297
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
CEREBELLAR HYPOPLASIA	0.00122699	0.04332307729680297
HAWKINSINURIA	0.00122699	0.04332307729680297
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.04332307729680297
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00122699	0.04332307729680297
GRANT SYNDROME	0.00122699	0.04332307729680297
FRYNS-SMEETS-THIRY SYNDROME	0.00122699	0.04332307729680297
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.04332307729680297
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.04332307729680297
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.04332307729680297
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04332307729680297
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.04332307729680297
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.04332307729680297
MYOTONIC DYSTROPHY 1	0.00122699	0.04332307729680297
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04332307729680297
JUVENILE DERMATOMYOSITIS	0.00122699	0.04332307729680297
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04332307729680297
JUNG SYNDROME	0.00122699	0.04332307729680297
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04332307729680297
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.04332307729680297
ISOTRETINOIN SYNDROME	0.00122699	0.04332307729680297
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04332307729680297
SPONASTRIME DYSPLASIA	0.00122699	0.04332307729680297
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 1	0.00122699	0.04332307729680297
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.04332307729680297
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.04332307729680297
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.04332307729680297
SHPRINTZEN OMPHALOCELE SYNDROME	0.00122699	0.04332307729680297
OPSISMODYSPLASIA	0.00122699	0.04332307729680297
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.04332307729680297
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04332307729680297
DESBUQUOIS DYSPLASIA 1	0.00122699	0.04332307729680297
OPSISMODYSPLASIA; OPSMD	0.00122699	0.04332307729680297
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.04332307729680297
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680297
OSTEOPENIA AND SPARSE HAIR	0.00122699	0.04332307729680297
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.04332307729680297
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00122699	0.04332307729680297
ARTERIAL TORTUOSITY SYNDROME	0.00122699	0.04332307729680297
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.04332307729680297
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.04332307729680297
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.04332307729680297
CHIARI MALFORMATION TYPE II	0.00122699	0.04332307729680297
KYPHOMELIC DYSPLASIA	0.00122699	0.04332307729680297
INTESTINAL BOTULISM	0.00122699	0.04332307729680297
PRADER-WILLI SYNDROME (TYPE 2)	0.00122699	0.04332307729680297
INFANT BOTULISM	0.00122699	0.04332307729680297
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.04332307729680297
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.04332307729680297
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.04332307729680297
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00122699	0.04332307729680297
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.04332307729680297
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04332307729680297
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.04332307729680297
NEONATAL MARFAN SYNDROME	0.00122699	0.04332307729680297
VELOCARDIOFACIAL SYNDROME	0.00122699	0.04332307729680297
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680297
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00122699	0.04332307729680297
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.04332307729680297
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00122699	0.04332307729680297
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00122699	0.04332307729680297
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.04332307729680297
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.04332307729680297
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00122699	0.04332307729680297
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00122699	0.04332307729680297
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.04332307729680297
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00122699	0.04332307729680297
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.04332307729680297
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680297
LAURIN-SANDROW SYNDROME	0.00122699	0.04332307729680297
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00122699	0.04332307729680297
SMITH-MAGENIS SYNDROME	0.00122699	0.04332307729680297
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00122699	0.04332307729680297
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00122699	0.04332307729680297
AICARDI-GOUTIRES SYNDROME	0.001086973	0.03837929836309816
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03837929836309816
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03837929836309816
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03837929836309816
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.03837929836309816
LISSENCEPHALY 4	0.001086973	0.03837929836309816
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03837929836309816
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.03837929836309816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03837929836309816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03837929836309816
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.03837929836309816
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.03837929836309816
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03837929836309816
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.03837929836309816
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03837929836309816
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03837929836309816
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309816
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.03837929836309816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.03837929836309816
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.03837929836309816
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03837929836309816
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.03837929836309816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.03837929836309816
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.03837929836309816
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03837929836309816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03837929836309816
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03837929836309816
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.001086973	0.03837929836309816
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03837929836309816
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309816
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03837929836309816
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03837929836309816
KBG SYNDROME	0.001086973	0.03837929836309816
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03837929836309816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.03837929836309816
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03837929836309816
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03837929836309816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03837929836309816
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03837929836309816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03837929836309816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03837929836309816
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.03837929836309816
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03837929836309816
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.03837929836309816
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03837929836309816
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03837929836309816
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.03837929836309816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03837929836309816
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.03837929836309816
KEUTEL SYNDROME	0.001086973	0.03837929836309816
SULFOCYSTEINURIA	0.001086973	0.03837929836309816
TIMOTHY SYNDROME; TS	0.001086973	0.03837929836309816
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03837929836309816
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.03837929836309816
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03837929836309816
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03837929836309816
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.03837929836309816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03837929836309816
SIALIDOSIS TYPE 2	0.001086973	0.03837929836309816
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309816
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03837929836309816
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03837929836309816
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03837929836309816
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03837929836309816
LANDAU-KLEFFNER SYNDROME	0.001086973	0.03837929836309816
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.03837929836309816
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03837929836309816
BAND HETEROTOPIA; BH	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03837929836309816
MEND SYNDROME; MEND	0.001086973	0.03837929836309816
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.03837929836309816
PETTIGREW SYNDROME	0.001086973	0.03837929836309816
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.03837929836309816
GRISCELLI SYNDROME TYPE 1	0.001086973	0.03837929836309816
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.03837929836309816
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03837929836309816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03837929836309816
WAISMAN SYNDROME; WSMN	0.001086973	0.03837929836309816
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.03837929836309816
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.03837929836309816
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.03837929836309816
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03837929836309816
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03837929836309816
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03837929836309816
XQ25 DUPLICATION SYNDROME	0.001086973	0.03837929836309816
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.03837929836309816
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03837929836309816
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03837929836309816
GLASS SYNDROME	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.03837929836309816
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.03837929836309816
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.03837929836309816
HARTNUP DISORDER	0.001086973	0.03837929836309816
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03837929836309816
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.03837929836309816
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03837929836309816
NETHERTON SYNDROME	0.001086973	0.03837929836309816
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03837929836309816
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.03837929836309816
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03837929836309816
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03837929836309816
CITRULLINEMIA, CLASSIC	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03837929836309816
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03837929836309816
PHACE ASSOCIATION	0.001086973	0.03837929836309816
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03837929836309816
LISSENCEPHALY 1; LIS1	0.001086973	0.03837929836309816
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.03837929836309816
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03837929836309816
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.03837929836309816
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.03837929836309816
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03837929836309816
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.03837929836309816
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.03837929836309816
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.03837929836309816
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03837929836309816
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.03837929836309816
HOLOPROSENCEPHALY 7	0.001086973	0.03837929836309816
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03837929836309816
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309816
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03837929836309816
DYSTONIA-APHONIA SYNDROME	0.001086973	0.03837929836309816
15Q14 MICRODELETION SYNDROME	0.001086973	0.03837929836309816
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.03837929836309816
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309816
17Q12 MICRODELETION SYNDROME	0.001086973	0.03837929836309816
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03837929836309816
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.03837929836309816
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03837929836309816
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03837929836309816
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03837929836309816
L1 SYNDROME	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.03837929836309816
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.03837929836309816
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03837929836309816
MEND SYNDROME	0.001086973	0.03837929836309816
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03837929836309816
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.03837929836309816
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03837929836309816
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03837929836309816
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03837929836309816
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03837929836309816
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03837929836309816
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03837929836309816
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309816
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03837929836309816
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309816
EAST SYNDROME	0.001086973	0.03837929836309816
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.03837929836309816
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.03837929836309816
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03837929836309816
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.03837929836309816
ISOVALERIC ACIDEMIA	0.001086973	0.03837929836309816
MOSAIC TRISOMY 14	0.001086973	0.03837929836309816
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.03837929836309816
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03837929836309816
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03837929836309816
DISTAL TRISOMY 17Q	0.001086973	0.03837929836309816
WILSON-TURNER SYNDROME	0.001086973	0.03837929836309816
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03837929836309816
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.03837929836309816
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03837929836309816
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.03837929836309816
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03837929836309816
CITRULLINEMIA TYPE II	0.001086973	0.03837929836309816
DISTAL MONOSOMY 1Q	0.001086973	0.03837929836309816
8P11.2 DELETION SYNDROME	0.001086973	0.03837929836309816
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03837929836309816
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.03837929836309816
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03837929836309816
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.03837929836309816
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.03837929836309816
STT3A-CDG	0.001086973	0.03837929836309816
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.03837929836309816
COWDEN SYNDROME	0.001086973	0.03837929836309816
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.03837929836309816
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.03837929836309816
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03837929836309816
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.03837929836309816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03837929836309816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03837929836309816
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03837929836309816
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.03837929836309816
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.03837929836309816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.019262649338283155
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.019262649338283155
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.019262649338283155
NOONAN SYNDROME 5; NS5	0.000545554	0.019262649338283155
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.019262649338283155
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.019262649338283155
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.019262649338283155
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.019262649338283155
NOONAN SYNDROME 11; NS11	0.000545554	0.019262649338283155
OGDEN SYNDROME; OGDNS	0.000545554	0.019262649338283155
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.019262649338283155
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.019262649338283155
AUSTRALIA ANTIGEN	0.000545554	0.019262649338283155
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.019262649338283155
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.019262649338283155
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.019262649338283155
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.019262649338283155
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.019262649338283155
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.019262649338283155
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.019262649338283155
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.019262649338283155
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.019262649338283155
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.019262649338283155
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.019262649338283155
FRIAS SYNDROME	0.000545554	0.019262649338283155
NOONAN SYNDROME 3; NS3	0.000545554	0.019262649338283155
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.019262649338283155
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.019262649338283155
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.019262649338283155
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.019262649338283155
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.019262649338283155
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.019262649338283155
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.019262649338283155
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.019262649338283155
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.019262649338283155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.019262649338283155
OTOFACIOCERVICAL SYNDROME	0.000545554	0.019262649338283155
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.019262649338283155
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.019262649338283155
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.019262649338283155
JAWAD SYNDROME	0.000545554	0.019262649338283155
EVEN-PLUS SYNDROME	0.000545554	0.019262649338283155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.019262649338283155
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.019262649338283155
NOONAN SYNDROME 6; NS6	0.000545554	0.019262649338283155
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.019262649338283155
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.019262649338283155
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.019262649338283155
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.019262649338283155
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.019262649338283155
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.019262649338283155
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.019262649338283155
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.019262649338283155
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.019262649338283155
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.019262649338283155
JOUBERT SYNDROME 27	0.000545554	0.019262649338283155
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.019262649338283155
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.019262649338283155
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.019262649338283155
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.019262649338283155
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.019262649338283155
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.019262649338283155
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.019262649338283155
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.019262649338283155
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.019262649338283155
TEMTAMY SYNDROME	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.019262649338283155
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.019262649338283155
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.019262649338283155
WEAVER SYNDROME	0.000545554	0.019262649338283155
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283155
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.019262649338283155
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.019262649338283155
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.019262649338283155
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.019262649338283155
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.019262649338283155
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.019262649338283155
ICF SYNDROME	0.000545554	0.019262649338283155
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.019262649338283155
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.019262649338283155
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.019262649338283155
CURRY-JONES SYNDROME	0.000545554	0.019262649338283155
HYDROXYKYNURENINURIA	0.000545554	0.019262649338283155
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.019262649338283155
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.019262649338283155
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.019262649338283155
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.019262649338283155
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.019262649338283155
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.019262649338283155
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.019262649338283155
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.019262649338283155
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.019262649338283155
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.019262649338283155
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.019262649338283155
HYPERTRICHOSIS CUBITI	0.000545554	0.019262649338283155
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.019262649338283155
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.019262649338283155
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.019262649338283155
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.019262649338283155
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.019262649338283155
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.019262649338283155
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.019262649338283155
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.019262649338283155
TRISOMY 12P	0.000545554	0.019262649338283155
SAY-BARBER-MILLER SYNDROME	0.000545554	0.019262649338283155
HEREDITARY OROTIC ACIDURIA	0.000545554	0.019262649338283155
ZECHI-CEIDE SYNDROME	0.000545554	0.019262649338283155
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.019262649338283155
HOLMES-GANG SYNDROME	0.000545554	0.019262649338283155
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.019262649338283155
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.019262649338283155
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.019262649338283155
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.019262649338283155
LIG4 SYNDROME	0.000545554	0.019262649338283155
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.019262649338283155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.019262649338283155
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.019262649338283155
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.019262649338283155
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.019262649338283155
TRISOMY 8Q	0.000545554	0.019262649338283155
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.019262649338283155
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.019262649338283155
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.019262649338283155
NOONAN SYNDROME 2; NS2	0.000545554	0.019262649338283155
3Q29 MICRODELETION SYNDROME	0.000545554	0.019262649338283155
CDAGS SYNDROME	0.000545554	0.019262649338283155
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.019262649338283155
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.019262649338283155
MICROVILLUS INCLUSION DISEASE	0.000545554	0.019262649338283155
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.019262649338283155
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.019262649338283155
OXOGLUTARIC ACIDURIA	0.000545554	0.019262649338283155
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.019262649338283155
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.019262649338283155
DISTAL TRISOMY 18Q	0.000545554	0.019262649338283155
TRISOMY 9P	0.000545554	0.019262649338283155
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.019262649338283155
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.019262649338283155
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.019262649338283155
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.019262649338283155
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.019262649338283155
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.019262649338283155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.019262649338283155
SEPTOOPTIC DYSPLASIA	0.000545554	0.019262649338283155
SECKEL SYNDROME 8; SCKL8	0.000545554	0.019262649338283155
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.019262649338283155
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.019262649338283155
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.019262649338283155
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.019262649338283155
OGDEN SYNDROME	0.000545554	0.019262649338283155
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.019262649338283155
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.019262649338283155
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.019262649338283155
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.019262649338283155
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283155
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.019262649338283155
CULLER-JONES SYNDROME; CJS	0.000545554	0.019262649338283155
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.019262649338283155
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.019262649338283155
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.019262649338283155
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.019262649338283155
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.019262649338283155
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.019262649338283155
STEEL SYNDROME; STLS	0.000545554	0.019262649338283155
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.019262649338283155
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.019262649338283155
JOUBERT SYNDROME 25	0.000545554	0.019262649338283155
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.019262649338283155
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.019262649338283155
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.019262649338283155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.019262649338283155
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.019262649338283155
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.019262649338283155
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.019262649338283155
8P23.1 DUPLICATION SYNDROME	0.000545554	0.019262649338283155
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.019262649338283155
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.019262649338283155
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.019262649338283155
JOUBERT SYNDROME 26	0.000545554	0.019262649338283155
48,XYYY SYNDROME	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.019262649338283155
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.019262649338283155
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.019262649338283155
NOONAN SYNDROME 9; NS9	0.000545554	0.019262649338283155
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.019262649338283155
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.019262649338283155
CHOPS SYNDROME; CHOPS	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.019262649338283155
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.019262649338283155
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.019262649338283155
AL-RAQAD SYNDROME; ARS	0.000545554	0.019262649338283155
MECKEL SYNDROME 13; MKS13	0.000545554	0.019262649338283155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.019262649338283155
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.019262649338283155
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.019262649338283155
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.019262649338283155
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.019262649338283155
AU-KLINE SYNDROME; AUKS	0.000545554	0.019262649338283155
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.019262649338283155
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.019262649338283155
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.019262649338283155
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 2	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.019262649338283155
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.019262649338283155
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.019262649338283155
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.019262649338283155
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.019262649338283155
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.019262649338283155
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.019262649338283155
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.019262649338283155
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.019262649338283155
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.019262649338283155
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.019262649338283155
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.019262649338283155
RIDDLE SYNDROME	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.019262649338283155
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.019262649338283155
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.019262649338283155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.019262649338283155
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.019262649338283155
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.019262649338283155
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.019262649338283155
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.019262649338283155
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.019262649338283155
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.019262649338283155
ALAZAMI SYNDROME; ALAZS	0.000545554	0.019262649338283155
JOUBERT SYNDROME 28	0.000545554	0.019262649338283155
OROTIC ACIDURIA	0.000545554	0.019262649338283155
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.019262649338283155
RIGID SPINE SYNDROME	0.000545554	0.019262649338283155
HOLOPROSENCEPHALY 11	0.000545554	0.019262649338283155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.019262649338283155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.019262649338283155
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.019262649338283155
ABETAL34V AMYLOIDOSIS	0.000545554	0.019262649338283155
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.019262649338283155
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.019262649338283155
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283155
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.019262649338283155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.019262649338283155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.019262649338283155
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.019262649338283155
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.019262649338283155
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.019262649338283155
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.019262649338283155
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.019262649338283155
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.019262649338283155
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.019262649338283155
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.019262649338283155
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.019262649338283155
ATELOSTEOGENESIS TYPE III	0.000545554	0.019262649338283155
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.019262649338283155
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.019262649338283155
DEXTROCARDIA	0.000545554	0.019262649338283155
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.019262649338283155
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.019262649338283155
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.019262649338283155
PELLAGRA-LIKE SYNDROME	0.000545554	0.019262649338283155
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.019262649338283155
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.019262649338283155
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.019262649338283155
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.019262649338283155
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.019262649338283155
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.019262649338283155
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.019262649338283155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.019262649338283155
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.019262649338283155
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.019262649338283155
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.019262649338283155
JOUBERT SYNDROME 15	0.000545554	0.019262649338283155
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.019262649338283155
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.019262649338283155
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.019262649338283155
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.019262649338283155
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.019262649338283155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.019262649338283155
RAINE SYNDROME	0.000545554	0.019262649338283155
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.019262649338283155
OPITZ G/BBB SYNDROME	0.000545554	0.019262649338283155
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.01911664902481501
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.01911664902481501
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.01911664902481501
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.01911664902481501
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.01911664902481501
HYPER-BETA-ALANINEMIA	0.000541419	0.01911664902481501
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.01911664902481501
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.01911664902481501
EBOLA HEMORRHAGIC FEVER	0.000541419	0.01911664902481501
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.01911664902481501
KIFAFA SEIZURE DISORDER	0.000541419	0.01911664902481501
LUJO HEMORRHAGIC FEVER	0.000541419	0.01911664902481501
RAMON SYNDROME	0.000541419	0.01911664902481501
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.01911664902481501
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.01911664902481501
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.01911664902481501
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.01911664902481501
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.01911664902481501
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.01911664902481501
CYSTATHIONINURIA	0.000541419	0.01911664902481501
HEREDITARY HYPEREKPLEXIA	0.000541419	0.01911664902481501
HENNEKAM SYNDROME	0.000541419	0.01911664902481501
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.01911664902481501
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.01911664902481501
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.01911664902481501
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.01911664902481501
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.01911664902481501
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.01911664902481501
GITELMAN SYNDROME	0.000541419	0.01911664902481501
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.01911664902481501
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.01911664902481501
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.01911664902481501
HYPERPROLINEMIA, TYPE II	0.000541419	0.01911664902481501
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.01911664902481501
SYSTEMIC SCLEROSIS	0.000541419	0.01911664902481501
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.01911664902481501
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.01911664902481501
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.01911664902481501
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.01911664902481501
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.01911664902481501
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.01911664902481501
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.01911664902481501
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.01911664902481501
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.01911664902481501
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.01911664902481501
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01911664902481501
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.01911664902481501
PARIETAL FORAMINA	0.000541419	0.01911664902481501
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.01911664902481501
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.01911664902481501
SNEDDON SYNDROME	0.000541419	0.01911664902481501
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.01911664902481501
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.01911664902481501
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.01911664902481501
STURGE-WEBER SYNDROME	0.000541419	0.01911664902481501
MOYAMOYA DISEASE	0.000541419	0.01911664902481501
RAMON SYNDROME	0.000541419	0.01911664902481501
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.01911664902481501
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.01911664902481501
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.01911664902481501
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.01911664902481501
LASSA FEVER	0.000541419	0.01911664902481501
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.01911664902481501
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.01911664902481501
CRONKHITE-CANADA SYNDROME	0.000541419	0.01911664902481501
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.01911664902481501
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.01911664902481501
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.01911664902481501
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.01911664902481501
PAPILLORENAL SYNDROME	0.000541419	0.01911664902481501
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.01911664902481501
DARIER-WHITE DISEASE; DAR	0.000541419	0.01911664902481501
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.01911664902481501
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.01911664902481501
FLYNN-AIRD SYNDROME	0.000541419	0.01911664902481501
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.01911664902481501
NASU-HAKOLA DISEASE	0.000541419	0.01911664902481501
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.01911664902481501
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.01911664902481501
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.01911664902481501
PORENCEPHALY	0.000541419	0.01911664902481501
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.01911664902481501
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.01911664902481501
ISOLATED BILIARY ATRESIA	0.000541419	0.01911664902481501
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.01911664902481501
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.01911664902481501
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.01911664902481501
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.01911664902481501
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.01911664902481501
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.01911664902481501
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.01911664902481501
DIAMINOPENTANURIA	0.000541419	0.01911664902481501
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.01911664902481501
2Q33.1 DELETION SYNDROME	0.000541419	0.01911664902481501
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.01911664902481501
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.01911664902481501
ASPARTYLGLUCOSAMINURIA	0.000541419	0.01911664902481501
EPILEPSY-TELANGIECTASIA	0.000541419	0.01911664902481501
FOUNTAIN SYNDROME	0.000541419	0.01911664902481501
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.01911664902481501
FRYNS SYNDROME; FRNS	0.000541419	0.01911664902481501
BERNARD-SOULIER SYNDROME	0.000541419	0.01911664902481501
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.01911664902481501
SECONDARY SYRINGOMYELIA	0.000541419	0.01911664902481501
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.01911664902481501
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.01911664902481501
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.01911664902481501
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.01911664902481501
ALEXANDER DISEASE	0.000541419	0.01911664902481501
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.01911664902481501
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.01911664902481501
SUBEPENDYMOMA	0.000541419	0.01911664902481501
EPENDYMOMA	0.000541419	0.01911664902481501
NIPAH VIRUS DISEASE	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.01911664902481501
JUVENILE HUNTINGTON DISEASE	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.01911664902481501
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.01911664902481501
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.01911664902481501
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.01911664902481501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.01911664902481501
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.01911664902481501
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.01911664902481501
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.01911664902481501
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.01911664902481501
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.01911664902481501
MOYNAHAN SYNDROME	0.000541419	0.01911664902481501
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.01911664902481501
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.01911664902481501
MYASTHENIA GRAVIS	0.000541419	0.01911664902481501
RECURRENT ACUTE PANCREATITIS	0.000541419	0.01911664902481501
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.01911664902481501
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.01911664902481501
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.01911664902481501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.01911664902481501
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.01911664902481501
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.01911664902481501
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.01911664902481501
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.01911664902481501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.01911664902481501
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.01911664902481501
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.01911664902481501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.01911664902481501
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.01911664902481501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.01911664902481501
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.01911664902481501
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.01911664902481501
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.01911664902481501
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.01911664902481501
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.01911664902481501
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.01911664902481501
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.01911664902481501
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.01911664902481501
PERRAULT SYNDROME 3	0.000541419	0.01911664902481501
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.01911664902481501
NEVUS COMEDONICUS SYNDROME	0.000541419	0.01911664902481501
EPISODIC ATAXIA, TYPE 6	0.000541419	0.01911664902481501
LHERMITTE-DUCLOS DISEASE	0.000541419	0.01911664902481501
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.01911664902481501
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.01911664902481501
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.01911664902481501
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.01911664902481501
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.01911664902481501
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.01911664902481501
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.01911664902481501
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.01911664902481501
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.01911664902481501
KLEEFSTRA SYNDROME	0.000541419	0.01911664902481501
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.01911664902481501
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.01911664902481501
ADIPOSIS DOLOROSA	0.000541419	0.01911664902481501
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.01911664902481501
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.01911664902481501
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.01911664902481501
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.01911664902481501
LISSENCEPHALY 3; LIS3	0.000541419	0.01911664902481501
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.01911664902481501
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.01911664902481501
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.01911664902481501
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.01911664902481501
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.01911664902481501
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.01911664902481501
HYPERPROLINEMIA TYPE 1	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.01911664902481501
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.01911664902481501
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.01911664902481501
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.01911664902481501
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.01911664902481501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.01911664902481501
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.01911664902481501
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.01911664902481501
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.01911664902481501
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.01911664902481501
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.01911664902481501
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.01911664902481501
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.01911664902481501
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.01911664902481501
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.01911664902481501
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.01911664902481501
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.01911664902481501
PSEUDO-TORCH SYNDROME 2	0.000541419	0.01911664902481501
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.01911664902481501
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.01911664902481501
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.01911664902481501
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.01911664902481501
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.01911664902481501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.01911664902481501
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.01911664902481501
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.01911664902481501
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.01911664902481501
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.01911664902481501
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.01911664902481501
LIPOID PROTEINOSIS	0.000541419	0.01911664902481501
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.01911664902481501
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.01911664902481501
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.01911664902481501
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.01911664902481501
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.01911664902481501
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.01911664902481501
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.01911664902481501
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.01911664902481501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.01911664902481501
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.01911664902481501
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.01911664902481501
COWDEN SYNDROME 5; CWS5	0.000541419	0.01911664902481501
COWDEN SYNDROME 6; CWS6	0.000541419	0.01911664902481501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.01911664902481501
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.01911664902481501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.01911664902481501
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.01911664902481501
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.01911664902481501
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.01911664902481501
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.01911664902481501
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.01911664902481501
PORPHYRIA	0.000541419	0.01911664902481501
ALZHEIMER DISEASE 3; AD	0.000541419	0.01911664902481501
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.01911664902481501
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.01911664902481501
ENCEPHALITIS LETHARGICA	0.000541419	0.01911664902481501
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.01911664902481501
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.01911664902481501
SCRUB TYPHUS	0.000541419	0.01911664902481501
CENTRAL DIABETES INSIPIDUS	0.000541419	0.01911664902481501
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.01911664902481501
MERCURY POISONING	0.000541419	0.01911664902481501
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.01911664902481501
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.01911664902481501
FABRY DISEASE	0.000541419	0.01911664902481501
TETRASOMY 18P	0.000541419	0.01911664902481501
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.01911664902481501
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.01911664902481501
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.01911664902481501
GRISCELLI SYNDROME TYPE 2	0.000541419	0.01911664902481501
PORPHYRIA VARIEGATA	0.000541419	0.01911664902481501
HHHH SYNDROME	0.000541419	0.01911664902481501
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.01911664902481501
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.01911664902481501
THYROCEREBRORENAL SYNDROME	0.000541419	0.01911664902481501
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.01911664902481501
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.01911664902481501
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.01911664902481501
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.01911664902481501
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.01911664902481501
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.01911664902481501
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.01911664902481501
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.01911664902481501
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.01911664902481501
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.01911664902481501
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.01911664902481501
THYROCEREBRORETINAL SYNDROME	0.000541419	0.01911664902481501
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.01911664902481501
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.01911664902481501
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.01911664902481501
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.01911664902481501
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.01911664902481501
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.01911664902481501
FRONTAL ENCEPHALOCELE	0.000541419	0.01911664902481501
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.01911664902481501
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.01911664902481501
ATKIN-FLAITZ SYNDROME	0.000541419	0.01911664902481501
ADDISON DISEASE	0.000541419	0.01911664902481501
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.01911664902481501
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.01911664902481501
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.01911664902481501
CLARK-BARAITSER SYNDROME	0.000541419	0.01911664902481501
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.01911664902481501
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.01911664902481501
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.01911664902481501
EPISODIC ATAXIA TYPE 3	0.000541419	0.01911664902481501
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.01911664902481501
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.01911664902481501
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.01911664902481501
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.01911664902481501
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.01911664902481501
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.01911664902481501
GALACTOSIALIDOSIS	0.000541419	0.01911664902481501
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.01911664902481501
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.01911664902481501
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.01911664902481501
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.01911664902481501
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.01911664902481501
BETA-MANNOSIDOSIS	0.000541419	0.01911664902481501
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.01911664902481501
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.01911664902481501
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.01911664902481501
RABIES	0.000541419	0.01911664902481501
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.01911664902481501
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.01911664902481501
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.01911664902481501
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.01911664902481501
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.01911664902481501
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.01911664902481501
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.01911664902481501
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.01911664902481501
WORSTER-DROUGHT SYNDROME	0.000541419	0.01911664902481501
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.01911664902481501
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.01911664902481501
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.01911664902481501
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.01911664902481501
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.01911664902481501
ROSA-DORFMAN DISEASE	0.000541419	0.01911664902481501
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.01911664902481501
MOGS-CDG	0.000541419	0.01911664902481501
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.01911664902481501
ALG2-CDG	0.000541419	0.01911664902481501
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.01911664902481501
VIRAL HEMORRHAGIC FEVER	0.000541419	0.01911664902481501
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.01911664902481501
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.01911664902481501
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.01911664902481501
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.01911664902481501
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.01911664902481501
CRISPONI SYNDROME	0.000541419	0.01911664902481501
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.01911664902481501
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.01911664902481501
HEREDITARY COPROPORPHYRIA	0.000541419	0.01911664902481501
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.01911664902481501
GURRIERI SYNDROME	0.000541419	0.01911664902481501
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.01911664902481501
WHIPPLE DISEASE	0.000541419	0.01911664902481501
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.01911664902481501
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.01911664902481501
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.01911664902481501
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.01911664902481501
